Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8374447097219815,-2.2735655047084324,0.0,0.0,0.0,8/22,6.28%,ALDH1A2;NR2F2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4;CRABP2
prerank,cation channel activity (GO:0005261),-0.5343742206521602,-1.9450075705272905,0.0,0.026745070396408763,0.048,26/94,12.81%,SLC24A3;TRPM3;NALCN;PIEZO2;MCU;ANXA2;PKD1;KCNK5;ANO6;PKD2;TRPC3;ABCC9;TRPM6;ANXA6;KCNQ4;ANO1;CALHM2;CACNA1D;CALHM5;TRPC6;TRPM4;SLC24A5;TMEM175;CACNB2;PSEN1;PANX1
prerank,sialyltransferase activity (GO:0008373),0.7910516143382096,1.8672364981986542,0.001736111111111111,0.23541303341993805,0.183,6/20,2.39%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;ST3GAL1;ST6GALNAC2
prerank,metalloendopeptidase activity (GO:0004222),-0.532552981136996,-1.8641780292617558,0.0,0.08188614146060955,0.198,24/76,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;MMP14;MMP16;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8177117539648925,1.8425088971053982,0.0,0.13078501856663227,0.282,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8177117539648925,1.8425088971053982,0.0,0.13078501856663227,0.282,3/16,0.40%,PTPRG;PTPRM;PTPRB
prerank,retinoic acid binding (GO:0001972),-0.7719104695023307,-1.8250513866156544,0.006787330316742082,0.10475152571926766,0.317,4/12,17.21%,NR2F2;CYP26B1;RXRA;RARA
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.7010406395317108,1.8087761013378263,0.0030816640986132513,0.17781732332040195,0.456,5/30,4.15%,SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1
prerank,monocarboxylic acid binding (GO:0033293),-0.6911795681794357,-1.7784668692717036,0.004750593824228029,0.1553195199317368,0.494,7/18,22.37%,NR2F2;CYP26B1;RXRA;NR1H4;RARA;PSAP;PYGL
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6932501253381735,1.7750017802306681,0.0015923566878980893,0.2327973330486054,0.622,5/32,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.5535566106906321,-1.7678239141272523,0.002785515320334262,0.1490790035059081,0.542,13/48,10.59%,TRPM3;NALCN;PIEZO2;SLC41A1;SLC12A2;PKD2;ABCC9;TRPM6;SLC12A7;CALHM2;CALHM5;TRPC6;TRPM4
prerank,death receptor activity (GO:0005035),0.83315651626886,1.7454757683241657,0.0018975332068311196,0.2904098104582142,0.761,4/11,2.32%,TNFRSF19;FAS;TNFRSF25;TNFRSF11A
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7348259481943026,-1.7444829098378762,0.002304147465437788,0.1606119306874283,0.61,4/13,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,BMP receptor binding (GO:0070700),-0.7348271184954636,-1.7202957144542417,0.002257336343115124,0.18981570795228997,0.725,4/12,1.89%,BMP6;BMP5;BMP7;BMP4
prerank,protein phosphatase 2A binding (GO:0051721),0.7109094498572139,1.7174212847123922,0.006956521739130435,0.36447341437909825,0.874,5/23,4.92%,MFHAS1;DAB2IP;CTTNBP2NL;FOXO1;STRN4
prerank,cAMP binding (GO:0030552),0.8206238185155772,1.7128129737737297,0.0076481835564053535,0.33765170658789195,0.889,5/11,8.10%,PDE2A;RAPGEF2;PDE4D;RAPGEF4;PDE4B
prerank,platelet-derived growth factor binding (GO:0048407),-0.7513711575456381,-1.7086894448050243,0.012738853503184714,0.19128778744427338,0.78,7/11,2.17%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,cation transmembrane transporter activity (GO:0008324),0.6144486791634541,1.6931516345822821,0.0077279752704791345,0.3885544654167639,0.946,5/48,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC38A5
prerank,leak channel activity (GO:0022840),-0.65299058661954,-1.6909063368569546,0.01927710843373494,0.20613515368491345,0.835,5/18,12.81%,KCNK2;NALCN;KCNK5;TMEM175;PANX1
prerank,acylglycerol lipase activity (GO:0047372),0.8106693763674981,1.6703283903687616,0.013409961685823755,0.4526167681009835,0.975,2/11,2.92%,ABHD2;LIPE
prerank,anion transmembrane transporter activity (GO:0008509),0.7843308855839368,1.6641981718491026,0.019120458891013385,0.4404619925992314,0.979,3/12,1.24%,ABCG2;SLCO2B1;SLC39A8
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5920354210323436,1.6587611271118068,0.006230529595015576,0.43033301301443805,0.983,6/51,3.10%,SLCO1C1;SLC7A5;MFSD2A;SLCO2B1;SLC16A2;SLC22A8
prerank,phospholipid transfer activity (GO:0120014),0.6950200552760943,1.6565790832285372,0.016611295681063124,0.40636220857596805,0.985,12/21,17.57%,CERT1;PLTP;PITPNC1;PRELID2;PITPNA;ABCA3;MTTP;GLTP;PLEKHA3;PITPNB;TRIAP1;C2CD2L
prerank,metallopeptidase activity (GO:0008237),-0.4390145165723112,-1.6452360384330689,0.0,0.30410135598879595,0.947,27/113,11.61%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;PAPPA;ADAMTS6;ADAMTSL5;MMP14;MMP16;ANPEP;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;ADAMTS15;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;ADAM33;IDE;ADAMTS1;MMP19;AFG3L2
prerank,protease binding (GO:0002020),-0.45117332317583575,-1.643004206816495,0.0,0.28404255319148936,0.951,22/99,8.93%,COL1A2;COL3A1;COL1A1;TIMP2;CCBE1;TIMP3;SLC2A13;ANXA2;ATP9A;STIM1;F3;AMFR;ADAMTSL4;FAP;ECM1;LCOR;BCL2;PRKN;SELENOS;BDKRB2;LDLR;DPP4
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.6855549274323598,1.6351861443353641,0.028052805280528052,0.46787981092711134,0.992,3/20,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,alanine transmembrane transporter activity (GO:0022858),0.7589881444014649,1.6252858436606172,0.02527075812274368,0.48464233033973575,0.996,2/12,1.98%,SLC6A6;SLC38A5
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6898162404088509,-1.624857330726296,0.008791208791208791,0.31507369256168155,0.972,8/12,24.61%,SULF1;SULF2;ARSI;ARSB;GNS;GALNS;ARSG;SGSH
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5124457566693251,1.6135964714636133,0.0013477088948787063,0.5059116631668862,0.997,11/134,1.98%,SLCO1C1;SLC6A6;SLC7A5;ABCC4;SLC7A1;ABCG2;SLC1A1;MFSD2A;SLCO2B1;SLC39A8;SLC38A5
prerank,calcium channel activity (GO:0005262),-0.46094490564379187,-1.6117169277092946,0.003236245954692557,0.33028039314930185,0.983,24/84,13.30%,SLC24A3;CACNA1C;CACNA2D3;MCU;ANXA2;PKD1;CACNA2D1;PKD2;TRPC3;ANXA6;P2RX4;CACNA1D;TRPC6;CACNB4;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;PSEN1;CATSPER3;PANX1;ORAI2;CACNB1
prerank,lipoprotein particle binding (GO:0071813),0.6813106444735734,1.6044792197083615,0.03648424543946932,0.5195301710391244,0.998,4/20,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,glycerophospholipid flippase activity (GO:0140333),0.7539603952282431,1.6001245616356834,0.03090909090909091,0.5098938993091394,0.998,6/11,9.75%,ATP10A;ATP8A1;ATP11A;ABCA3;ATP11C;ATP10B
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7406598412415033,-1.594280411089929,0.019067796610169493,0.3641952178671465,0.99,3/10,5.61%,SLC6A13;SLC6A12;SLC6A1
prerank,AMP binding (GO:0016208),-0.694458066194692,-1.5867526326229846,0.032188841201716736,0.3653302324287225,0.992,4/11,10.34%,PRKAG2;MPPED2;PFKP;PRKAG3
prerank,low-density lipoprotein particle binding (GO:0030169),0.7031658761255812,1.5842507891576874,0.04560810810810811,0.5541154734007314,1.0,4/16,2.93%,PLTP;STAB1;SCARF1;SCARB1
prerank,semaphorin receptor binding (GO:0030215),0.6470836079159933,1.5824998859750334,0.023769100169779286,0.5332004603101161,1.0,7/23,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,cadherin binding (GO:0045296),0.4566998831545512,1.5822930052563036,0.0,0.5086722810038466,1.0,55/315,9.26%,PROM1;COBLL1;PTPRM;ITGA6;PTPRB;BSG;DOCK9;TJP1;SPTBN1;KDR;DAB2IP;MACF1;ESYT2;WASF2;BMPR2;EPN2;MRTFB;FASN;TJP2;FNBP1L;TRIM25;FLNB;F11R;STK38;PTPRJ;LRRFIP1;CDH2;CD2AP;STXBP6;PPFIBP1;CDH20;TBC1D2;CTNND1;CTNNB1;HSP90AB1;CDH8;EIF4H;EPS8L2;MRE11;BAIAP2;DBNL;STAT1;PKN2;DCHS1;CDH19;PKP4;PKM;CTNNA3;TWF2;SPTAN1;EIF3E;IQGAP1;CLINT1;SLC3A2;CAPG
prerank,phospholipase inhibitor activity (GO:0004859),-0.6971330311854798,-1.564561011929117,0.03935185185185185,0.41568481962522896,0.996,4/10,5.77%,ANXA2;ANXA1;ANXA4;ANXA5
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7554750972471085,1.5629101753816659,0.041044776119402986,0.5713384692208054,1.0,2/11,1.14%,SGMS1;SGMS2
prerank,solute:anion antiporter activity (GO:0140323),-0.6640835017308139,-1.5609530124986561,0.026030368763557483,0.4046980405250824,0.996,4/14,8.95%,SLC7A11;SLC26A7;SLC26A2;SLC4A2
prerank,cell adhesion mediator activity (GO:0098631),0.642653156621231,1.560377717453752,0.043327556325823226,0.559751131303409,1.0,7/24,11.16%,BSG;ESAM;ROBO4;DSCAML1;CNTN2;BCAM;PLXNB3
prerank,amyloid-beta binding (GO:0001540),0.5242609784445414,1.5561464817388757,0.009900990099009901,0.5545368623775572,1.0,18/79,11.28%,ITM2A;INSR;CACNA1A;APBB2;FZD6;TGFB2;BCHE;FZD4;CLSTN1;RAMP3;EPHA4;ATP1A3;GRIA4;APBA2;PFDN4;PFDN2;AGER;GRIN2B
prerank,peptidoglycan binding (GO:0042834),0.7488389992656185,1.5555224139262742,0.05197132616487455,0.53481012207709,1.0,3/10,3.20%,PGLYRP1;NOD1;NOD2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6545986763375944,-1.5555200599909242,0.03036876355748373,0.40023763242345045,0.996,8/15,14.18%,HS3ST3A1;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2;NDST2;NDST4;NDST1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.48600849744400776,1.5545229729692085,0.0039011703511053317,0.5180324936597848,1.0,37/147,10.86%,DOCK4;DOCK9;FGD5;PREX2;RAPGEF2;RASGRF2;DENND3;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;ARHGEF2;KALRN;RAPGEF1;TIAM1;ABR;RIN3;RAPGEF3;DENND5B;CYTH3;EPS8L2;CCDC88A;DENND4C;RAPGEF4;SOS1;RASGRP2;RGL2;ARHGEF5;PREX1;ARHGEF7;FGD6;EIF2B1;EIF2B2;DENND1B;LAMTOR5
prerank,phosphatidylcholine transporter activity (GO:0008525),0.6940317634653764,1.55381666725862,0.03716814159292035,0.501528874617342,1.0,9/17,11.60%,ATP10A;PLTP;ABCG1;PITPNC1;PITPNA;ABCA3;ABCA7;ATP10B;MTTP
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.733483123634104,1.5515962990058485,0.046065259117082535,0.4928870562354565,1.0,3/11,2.56%,DAB2IP;MAP4K2;STK38
prerank,pentosyltransferase activity (GO:0016763),-0.5140123684771892,-1.5489563947511935,0.023255813953488372,0.399838802426311,0.997,15/36,16.88%,LARGE1;PARP8;PARP3;LACC1;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;UPP2;SIRT2;QPRT;TIPARP;UMPS
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6411553488765722,-1.547341577285916,0.045146726862302484,0.3852327864682017,0.997,4/15,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7235314986923134,1.5441260034174678,0.050724637681159424,0.5055170531970731,1.0,6/12,12.15%,PIK3R6;PIK3R3;PIK3C3;PIK3C2A;IPMK;PIK3CB
prerank,FAD binding (GO:0071949),-0.5606472339827532,-1.5427016021251356,0.037825059101654845,0.38145494343160785,0.999,11/24,20.48%,MICAL3;DDO;MICAL2;PRODH;MTHFR;CRY2;MICAL1;SQOR;SQLE;KMO;AGPS
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6555744094091697,-1.5379292329295884,0.03303964757709251,0.3772734567995825,1.0,4/12,4.30%,GAB2;IRS1;SHC1;FRS2
prerank,glutamate receptor binding (GO:0035254),0.6680868304353417,1.535708701716476,0.06020066889632107,0.5212286009182475,1.0,4/17,6.43%,HIP1;SHANK3;HOMER2;HOMER1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7402241254481179,1.5310946809937998,0.04638218923933209,0.5227181871098625,1.0,1/10,0.11%,MECOM
prerank,phosphatidylinositol binding (GO:0035091),0.5023246041252369,1.5295461558053876,0.019553072625698324,0.5134569526995765,1.0,18/91,7.28%,MCF2L;HIP1;MYO1E;ESYT2;FES;HIP1R;SCARB1;EPB41;PARD3;SNX13;PITPNC1;PITPNA;PIGU;CCDC88A;ESYT1;PLEKHF2;FCHO2;WDFY3
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6907747264647547,-1.5248178272151147,0.06625258799171843,0.3996076721883174,1.0,8/10,25.58%,AUH;ECHDC2;ECHDC1;ECHDC3;EHHADH;ECI1;HADHA;ECHS1
prerank,SH3 domain binding (GO:0017124),0.5278951484214276,1.5150500680821417,0.028315946348733235,0.5550894214594966,1.0,12/62,4.44%,SHANK3;DAB2IP;AFAP1L1;WASF2;ARHGAP27;ELMO1;AFAP1L2;ADAM15;PTPN12;CD2AP;EVL;GRB2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6878369348259475,-1.513437997212439,0.049783549783549784,0.4196004377747686,1.0,5/11,11.92%,ITPR1;TRPC3;TRPC6;ITPR2;TRPC4
prerank,Toll-like receptor binding (GO:0035325),0.7248437759556845,1.5126622299577375,0.05363984674329502,0.5478176094440339,1.0,4/11,11.08%,DAB2IP;TIRAP;TOLLIP;S100A8
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5945551074310828,1.5097157099467327,0.03924646781789639,0.5428584309119597,1.0,14/30,22.15%,RPS6KA1;VIL1;XIAP;BIRC3;CST7;SPOCK1;PTTG1;PRDX5;GAS6;CSTB;SERPINB9;UBE2Z;RPS6KA3;SNCA
prerank,fibroblast growth factor binding (GO:0017134),-0.5556064295074764,-1.5054454457104605,0.05868544600938967,0.42677817461619794,1.0,5/21,10.36%,FGFR2;THBS1;KL;API5;ITGAV
prerank,GTPase activator activity (GO:0005096),0.43411517523966864,1.5049284265822676,0.0011235955056179776,0.5460833435492652,1.0,58/313,8.64%,CHN2;PLCB1;RASGRP3;DOCK4;DOCK9;FGD5;ARHGAP31;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;RASGRF2;DENND3;RGS3;ARHGAP27;DOCK1;RASGRP4;ARHGEF15;ELMO1;CYTH1;SPATA13;TBC1D14;ARHGEF2;TBC1D22A;KALRN;RAPGEF1;SIPA1L2;SIPA1;TIAM1;ABR;RIN3;RALGAPA1;GNAQ;TBC1D12;STARD13;RAPGEF3;DENND5B;TBC1D2;CYTH3;USP6NL;EPS8L2;OCRL;CCDC88A;DENND4C;TBC1D5;RAPGEF4;RAP1GDS1;SOS1;RASGRP2;ARHGAP25;RGL2;JUN;ARHGEF5;IQGAP1;PREX1;ARHGEF7;OPHN1
prerank,protein tyrosine kinase activity (GO:0004713),0.4823310716511436,1.5045534550498616,0.021248339973439574,0.5326294654265613,1.0,21/108,6.86%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FES;FLT4;PTK2;JAK3;ZAP70;MERTK;LYN;CAMKK2;EPHA4;FYN;RET;YES1;AATK;EPHB4;HCK
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.5328671572353556,-1.5024796370826825,0.041025641025641026,0.4199599737005365,1.0,11/27,19.77%,ITPR1;SLC41A1;SLC12A2;CNNM2;SLC9B2;ITPR2;ATP2A3;ZDHHC13;MAGT1;ATP2B3;TUSC3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6340729739256815,-1.4965404032097083,0.06150341685649203,0.42356974584153717,1.0,4/13,7.90%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5486586890989084,1.480814648876109,0.04897314375987362,0.6116449967499809,1.0,8/42,6.91%,BSG;ESAM;ROBO4;CD200;DSCAML1;STXBP6;BAIAP2;CNTN2
prerank,pre-mRNA binding (GO:0036002),-0.5261868918074751,-1.4802271278023014,0.04473684210526316,0.45674978459869475,1.0,10/28,22.46%,CELF2;DDX5;RNPC3;SRSF6;RBM41;U2AF2;U2AF1;TRA2B;TARBP2;RBM24
prerank,GTPase regulator activity (GO:0030695),0.4359352401495775,1.4774629009761218,0.0023584905660377358,0.609762577687979,1.0,32/212,6.47%,CHN2;PLCB1;RASGRP3;ARHGAP31;RGS12;PREX2;ARAP3;TBC1D4;SRGAP2;RAPGEF2;SH3BP4;RGS3;ARHGAP27;DOCK1;ARL2BP;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;ABR;RALGAPA1;GNAQ;TBC1D12;STARD13;TBC1D2;USP6NL;OCRL;CCDC88A;TBC1D5;RAP1GDS1;SOS1;ARHGAP25
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.6069469217677708,1.467664563523336,0.06678082191780822,0.6344079439086022,1.0,5/24,7.17%,CERT1;DAB2IP;OSBP;SNX3;PLEKHA5
prerank,cyclic nucleotide binding (GO:0030551),0.6207127042405403,1.467608498728932,0.06486486486486487,0.6191308796385112,1.0,6/21,8.10%,PDE2A;RAPGEF2;CNGA2;PDE4D;RAPGEF4;PDE4B
prerank,chemorepellent activity (GO:0045499),0.5890065064791736,1.4664037751888654,0.0625,0.6092042815394062,1.0,6/25,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D
prerank,protein tyrosine kinase binding (GO:1990782),0.5008373746122157,1.463884215946756,0.0237741456166419,0.6052375036315223,1.0,10/71,5.52%,GRB14;DOCK4;BMPR2;TJP2;NEDD9;DUSP3;ELMO2;HYAL2;CD4;EPHA4
prerank,alkali metal ion binding (GO:0031420),-0.614520323803294,-1.4625365691921985,0.06277056277056277,0.4949819139661281,1.0,3/13,8.71%,ATP1A2;HDAC4;TDG
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5114898384366213,1.4612186338977682,0.04105571847507331,0.6013138467279479,1.0,12/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;ACVRL1;MERTK;EPHA4;RET;EPHB4
prerank,hexose transmembrane transporter activity (GO:0015149),0.6849014898741385,1.4559437653772331,0.07766990291262135,0.6088322069444608,1.0,1/12,0.45%,SLC2A1
prerank,metalloaminopeptidase activity (GO:0070006),-0.5769485926037645,-1.4557066484136716,0.08545034642032333,0.4993371745336675,1.0,5/16,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,phosphate ion binding (GO:0042301),0.7001911908186754,1.4542725232717566,0.1029126213592233,0.6021141047086878,1.0,3/10,11.08%,PDE2A;ADSS2;PNP
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5175285274350032,1.45119574561825,0.04626865671641791,0.6012043889494272,1.0,6/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A4;SLC16A2;SLC38A5
prerank,phosphatidylglycerol binding (GO:1901611),0.679807071567804,1.4468332014316074,0.08806262230919765,0.6048807108706742,1.0,3/13,5.12%,PLTP;PITPNC1;PITPNA
prerank,solute:sodium symporter activity (GO:0015370),-0.5227695607244602,-1.4450581061115226,0.05263157894736842,0.5186500630692463,1.0,7/27,15.91%,SLC4A10;SLC5A6;SLC20A2;SLC4A7;SLC5A3;SLC5A7;SLC20A1
prerank,poly(U) RNA binding (GO:0008266),-0.5562690951677519,-1.4449497553802348,0.06326034063260341,0.5032635805456671,1.0,7/20,16.38%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L
prerank,peptidase inhibitor activity (GO:0030414),-0.4882396722263814,-1.4432557120083327,0.06666666666666667,0.4940263166796333,1.0,6/33,10.14%,TIMP2;TFPI;GPC3;ITIH2;SERPIND1;RENBP
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.5420055773738557,-1.4408464302192934,0.07093821510297482,0.4867319795528444,1.0,4/21,4.69%,FGF1;FRS2;KL;FGF2
prerank,potassium ion leak channel activity (GO:0022841),-0.5868433040493106,-1.4393112492237639,0.08373205741626795,0.4772564259523765,1.0,2/15,3.08%,KCNK2;KCNK5
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5904133629426704,1.4382142549312193,0.07375643224699828,0.6243804081051576,1.0,4/26,1.67%,SLC6A6;ABCG2;SLC16A4;SLC16A2
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.44055897423777196,-1.434798448645697,0.03206997084548105,0.47686005395478764,1.0,14/55,12.81%,SLC24A3;ITPR1;MCU;ANXA2;PKD1;PKD2;TRPC3;ANXA6;CACNA1D;ITPR2;SLC24A5;CACNB2;PSEN1;PANX1
prerank,fatty acid synthase activity (GO:0004312),0.7057016156492005,1.4338915557454412,0.11338289962825279,0.6287338861800192,1.0,3/10,12.19%,ELOVL7;ELOVL5;ELOVL6
prerank,Hsp90 protein binding (GO:0051879),0.5529448126353392,1.4302904093457638,0.07779578606158834,0.6302930487543038,1.0,5/33,4.06%,KDR;UNC45B;NOD2;CYP2E1;FKBP6
prerank,estrogen receptor binding (GO:0030331),0.5664294818935465,1.4294570059342226,0.08166666666666667,0.6212094912952656,1.0,5/32,9.84%,LEF1;NCOA1;CTNNB1;TACC1;SRARP
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5273652088869455,-1.4265803499487266,0.05432098765432099,0.48975280955918893,1.0,8/23,19.38%,RBMS3;RBMS1;HNRNPH1;PATL1;FMR1;PABPC4;PABPC4L;U2AF2
prerank,mRNA 3'-UTR binding (GO:0003730),-0.4072885239309505,-1.4257598274448944,0.038834951456310676,0.47948094866420193,1.0,18/79,16.38%,CELF2;RBMS3;CPEB1;CPEB2;DDX5;RBMS1;AUH;CSDC2;YBX3;FXR2;IGF2BP2;RNF20;FMR1;PCBP4;HNRNPA2B1;PABPC4;TUT1;PABPC4L
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6856647914616962,1.4256915991016423,0.11475409836065574,0.623933753306996,1.0,2/11,4.52%,LEF1;GATA2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6190623307051396,-1.424734437838293,0.09166666666666666,0.4704160715279452,1.0,3/11,4.66%,KCNK2;KCNT2;PKD2
prerank,diacylglycerol kinase activity (GO:0004143),0.6899137346731203,1.420294815409736,0.12341197822141561,0.6323697842175497,1.0,4/11,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,insulin-like growth factor I binding (GO:0031994),0.6614827900270472,1.4180963938489684,0.11559633027522936,0.6292497096098904,1.0,3/13,0.95%,IGF1R;ITGA6;INSR
prerank,actin monomer binding (GO:0003785),0.5945091553554183,1.4173074443758844,0.08362369337979095,0.6207617488394795,1.0,6/22,8.14%,NOS3;MRTFA;MTSS1;TMSB4X;TMSB10;TWF2
prerank,frizzled binding (GO:0005109),-0.47338353167723696,-1.4119147894338244,0.059782608695652176,0.49515828163902226,1.0,14/34,20.28%,WNT4;WNT5B;RNF43;WNT6;WNT9A;FZD7;MYOC;DVL2;WNT11;LRP6;SFRP1;RYK;WNT16;DVL3
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.47681839804684667,-1.4108229605415983,0.05343511450381679,0.4869772606217356,1.0,8/31,12.59%,KCNK5;SLC12A2;PKD2;ABCC9;KCNQ4;SLC12A7;TMEM175;SLC12A4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6825974845058019,1.4095407664444115,0.1275797373358349,0.6381108719646454,1.0,3/10,5.22%,SLCO1C1;SLCO2B1;SLC22A7
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6672499283854654,1.4093491048901783,0.1063063063063063,0.6278548165857278,1.0,5/12,12.00%,CNOT6L;NOCT;PAN3;PAN2;CNOT6
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4596458387737073,-1.403533734003047,0.06835443037974684,0.4970759078498779,1.0,11/37,13.30%,CACNA1C;CACNA2D3;CACNA2D1;PKD2;CACNA1G;CACNA1D;CACNB4;ITGAV;CACNB2;CATSPER3;CACNB1
prerank,ATPase binding (GO:0051117),-0.4109806693099675,-1.4029431647980317,0.030612244897959183,0.4873546161123375,1.0,21/71,13.91%,ANK2;EGFR;SLC2A13;PTPN3;SNTA1;ABCA1;PKD2;AR;ATP6V0A4;ATP1B3;TMTC4;ATP1B2;SELENOS;EZR;TOR1AIP1;ESR1;PGR;PSEN1;SYVN1;NKD2;ATP5IF1
prerank,glutamate receptor activity (GO:0008066),0.601751562604358,1.3966440430968103,0.11912751677852348,0.6652131870041014,1.0,12/19,24.75%,GRID2;GRIA4;GRIK5;GRIK2;GRIK1;GRM7;GRM8;GRIA2;GRM2;GRM3;GRIK3;GRID1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.5275776110800035,-1.3951747272014894,0.06904231625835189,0.49864697916859896,1.0,3/22,2.18%,RBMS3;CPEB1;CPEB2
prerank,clathrin adaptor activity (GO:0035615),0.6273994341112623,1.3945566902631328,0.10265486725663717,0.6618895651176677,1.0,4/15,12.31%,HIP1;HIP1R;AP2M1;AP2B1
prerank,protein kinase C activity (GO:0004697),0.6288704404480137,1.3899743431545117,0.11376146788990826,0.6669211325091394,1.0,4/14,5.38%,PRKCH;PRKD1;PRKD3;PKN1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4481332333304879,1.389543173072428,0.05131761442441054,0.657916794392391,1.0,19/100,10.91%,CERT1;HIP1;ARAP3;MYO10;DAB2IP;ARAP2;HIP1R;PARD3;OSBP;SNX13;SNX3;CYTH3;TECPR1;PIRT;PLEKHA5;IQGAP1;CLVS2;DENND1B;FERMT2
prerank,glucose transmembrane transporter activity (GO:0005355),0.6142057271622829,1.3878270472043024,0.10676156583629894,0.6536855598321236,1.0,1/17,0.45%,SLC2A1
prerank,alpha-actinin binding (GO:0051393),-0.49856858648224056,-1.3867926875253882,0.0875,0.5139274155239062,1.0,8/24,7.86%,CACNA1C;PALLD;PDLIM7;DAG1;PKD2;PDLIM2;PDLIM4;CACNA1D
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.49752693118600577,-1.3841830801399193,0.0746987951807229,0.5106432707916374,1.0,10/25,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;TIPARP
prerank,insulin-like growth factor binding (GO:0005520),0.6236665121047876,1.3701128061530539,0.13577981651376148,0.7095716031367524,1.0,3/15,0.95%,IGF1R;ITGA6;INSR
prerank,poly-purine tract binding (GO:0070717),-0.49297371037123766,-1.369473438253663,0.09399477806788512,0.54404343430596,1.0,9/27,16.94%,RBMS3;RBMS1;DDX1;PATL1;FMR1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,histone demethylase activity (GO:0032452),-0.4734569756297322,-1.3678584571835104,0.09313725490196079,0.5380550216710625,1.0,13/27,23.80%,KDM7A;KDM2A;KDM3B;FBXL19;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,amino acid transmembrane transporter activity (GO:0015171),0.500713192943216,1.3645956976548033,0.09538461538461539,0.7201379105169546,1.0,6/47,2.87%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5;SLC43A2
prerank,actin binding (GO:0003779),0.41724204008281085,1.3628097403103263,0.03018867924528302,0.7155220928363969,1.0,32/170,8.14%,FLII;PARVB;UTRN;ABLIM1;SYNE1;MACF1;MYRIP;NOS3;KLHL2;SLC6A2;MRTFA;FLNB;CORO2B;PTK2;MTSS1;NOD2;VASH1;SSH2;MYO6;TMSB4X;EPS8;EPS8L2;CCDC88A;ACTN4;DBNL;PRICKLE4;PARVG;SORBS1;MSRB2;FHL3;TMSB10;TWF2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.6151032085206172,1.3625003796251254,0.15057915057915058,0.7060739297426808,1.0,4/15,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,poly(A) binding (GO:0008143),-0.5110170642616162,-1.3614882321611974,0.11662531017369727,0.5460749040048971,1.0,7/21,16.94%,RBMS3;RBMS1;DDX1;DDX3X;PABPC4;PABPC4L;HNRNPDL
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.47180915065787793,1.3598358263145243,0.08806818181818182,0.7055141606772616,1.0,11/60,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;MERTK;EPHA4;RET;EPHB4
prerank,motor activity (GO:0003774),0.4751531406043031,1.3517448056270132,0.10776545166402536,0.7254121548211433,1.0,12/60,12.40%,MYO1E;STARD9;KIFC3;MYO6;DNAH3;KIF26A;KIF2A;KIF1A;PIN1;KIF3B;KIF23;DNAH8
prerank,MHC class I protein binding (GO:0042288),0.6343661102388392,1.3510567060958023,0.14869888475836432,0.717406128768196,1.0,7/13,20.17%,PILRA;TUBB;TAP2;CD8B;ATP5F1A;TUBB4B;TAP1
prerank,endopeptidase activity (GO:0004175),-0.3255528428837002,-1.350738797937143,0.01948051948051948,0.5679200133558404,1.0,62/257,18.87%,TRABD2B;THSD4;ADAMTS2;ADAMTS12;ADAMTSL3;ADAMTS10;ADAMTS6;ADAMTSL5;PCSK5;MMP14;HTRA3;MMP16;F3;USP11;USP24;ADAMTS5;ADAM9;ADAMTS17;ADAMTSL4;FAP;BACE2;CTSL;ADAMTS15;USP40;ADAMTSL1;MMP2;ADAMTS16;ACE;ADAM19;KLK2;DPP4;USP2;ADAM33;IDE;RHBDL3;ADAMTS1;MMP19;AFG3L2;PSEN1;CTSH;USP42;USP9X;HTRA4;HTRA2;ADAMTS14;CTSZ;CASP3;MASP1;ACE2;ADAMTS9;NRDC;ZMPSTE24;PRSS12;RHBDF1;PARL;SFRP1;CASP6;CASP4;MBTPS1;PCSK6;GZMM;USP16
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6266961118092765,1.3484709577963316,0.16304347826086957,0.716554538343943,1.0,5/12,13.45%,DAB2IP;CCDC88A;GREM1;PGF;CDH5
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6241573634272988,1.3460053369350327,0.15636363636363637,0.7155170118333446,1.0,2/12,6.20%,ENTPD1;ENTPD5
prerank,MAP kinase phosphatase activity (GO:0033549),0.6357496381767349,1.3456563342641312,0.16195856873822975,0.7068730423940677,1.0,5/12,14.43%,DUSP7;DUSP3;DUSP1;DUSP16;DUSP8
prerank,transcription coactivator binding (GO:0001223),-0.5084055316359972,-1.3362355102488055,0.13752913752913754,0.6017069363328801,1.0,9/20,12.24%,SMAD3;THRB;CCNT2;RORA;AR;MED25;VGLL4;ESR1;PGR
prerank,cGMP binding (GO:0030553),0.630604888641238,1.335072462029651,0.17005545286506468,0.7355909562977935,1.0,3/11,3.81%,PDE2A;RAPGEF2;CNGA2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6119781837987496,-1.334387424032257,0.1425661914460285,0.5962599446936608,1.0,4/10,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,cardiolipin binding (GO:1901612),-0.5948688440920668,-1.3335877068597914,0.16765285996055226,0.5876761456033933,1.0,3/10,18.56%,GSDME;GSDMD;PLEKHN1
prerank,metalloexopeptidase activity (GO:0008235),-0.413295604568924,-1.3276193740128617,0.08708708708708708,0.5953974964544628,1.0,14/51,15.77%,CPQ;AEBP1;MMP14;MMP16;ANPEP;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;AGBL1;PEPD;ACE2;ZMPSTE24
prerank,mannosyltransferase activity (GO:0000030),0.5628130929716542,1.3264335884055778,0.15452930728241562,0.7559642350112508,1.0,1/21,0.08%,TMTC2
prerank,active ion transmembrane transporter activity (GO:0022853),0.5067501345461869,1.3262503713859581,0.14052287581699346,0.7467453914353097,1.0,4/37,5.22%,SLCO1C1;SLCO2B1;SLC22A8;SLC22A7
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5129622607624088,-1.3248364524455598,0.13024282560706402,0.5826741165179918,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.5129622607624088,-1.3248364524455598,0.13024282560706402,0.5826741165179918,1.0,4/17,7.23%,EPHA3;EPHA7;EPHA8;EPHB2
prerank,MHC protein binding (GO:0042287),0.5674270094861559,1.3247931919127525,0.163575042158516,0.7426263406901911,1.0,8/20,14.92%,PILRA;CD4;TUBB;TAP2;CD8B;KIR3DL2;ATP5F1A;TUBB4B
prerank,death domain binding (GO:0070513),0.633767760347227,1.3240434895818138,0.18299445471349354,0.7360075246041721,1.0,4/11,8.17%,BCL2L1;CRADD;MCL1;IRGM
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5660051430381674,1.3143066176893916,0.18315018315018314,0.7624244461133665,1.0,4/18,9.66%,PIK3R6;PIK3R3;SOCS2;SOCS5
prerank,carboxylic ester hydrolase activity (GO:0052689),0.44269665339588204,1.3134410494169166,0.08957415565345081,0.7561889169662241,1.0,11/85,10.76%,ABHD2;BCHE;LIPE;PLA2G4B;PNPLA6;NOTUM;GDPD1;ENPP2;LYPLA1;PTRH2;LIPC
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.4772484208161018,-1.3128662703704856,0.1457286432160804,0.6088175411821071,1.0,10/24,21.06%,CAMK1D;CAMK2D;MAPKAPK3;PHKA2;PTK2B;EEF2K;CAMK1;PHKG2;CAMKK1;PHKA1
prerank,double-stranded RNA binding (GO:0003725),0.4500406509172681,1.3128532918674247,0.11370262390670553,0.7489274296818004,1.0,19/70,16.71%,TFRC;LRRFIP1;IFIH1;ADAR;HSP90AB1;EIF4H;TLR3;ACTN1;TLR7;MSN;SLC3A2;OASL;TLR8;ADAD1;RFTN1;ELAVL1;TUBB4B;MRPL44;EIF4A1
prerank,phosphatidic acid binding (GO:0070300),0.5590446603995253,1.3117385216861128,0.15018315018315018,0.7435974850192322,1.0,3/19,4.75%,PLTP;RAPGEF2;PITPNC1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5853365427809288,1.3111795599311749,0.18181818181818182,0.7366505563843444,1.0,9/18,22.15%,RPS6KA1;VIL1;XIAP;BIRC3;PRDX5;GAS6;SERPINB9;RPS6KA3;SNCA
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.5158298954039703,1.3106149101356819,0.1744186046511628,0.7300965871631778,1.0,7/27,13.17%,RNF144B;DCUN1D3;FOXL2;RNF125;TOLLIP;UBE3D;DCUN1D1
prerank,CARD domain binding (GO:0050700),0.600471752807999,1.3105576087283122,0.18947368421052632,0.7218149450049444,1.0,6/14,15.35%,NOD1;NOD2;CARD10;IRGM;BCL10;CARD11
prerank,muscle alpha-actinin binding (GO:0051371),-0.540777234435891,-1.3097472618746044,0.1511627906976744,0.6081523446133802,1.0,5/15,7.75%,PALLD;PDLIM7;PKD2;PDLIM2;PDLIM4
prerank,myosin II binding (GO:0045159),0.6284300079398766,1.3095742918024347,0.18250950570342206,0.7169311849619522,1.0,2/10,1.44%,SHROOM4;SHROOM1
prerank,symporter activity (GO:0015293),0.6373235646253834,1.3082901608654753,0.19348659003831417,0.7126453690737765,1.0,1/10,0.46%,MFSD2A
prerank,phospholipase binding (GO:0043274),-0.5535698749740507,-1.3082422038108275,0.16519823788546256,0.6027216234765994,1.0,3/13,9.06%,ARHGAP6;PRKN;PDPK1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5521383894572951,1.3024072397256785,0.17043478260869566,0.7244849822206835,1.0,9/22,17.33%,DUSP23;DUSP7;DUSP3;DUSP12;DUSP1;DUSP16;DUSP8;MTMR2;PPM1F
prerank,transcription corepressor binding (GO:0001222),-0.4668219378462407,-1.301268160066846,0.12987012987012986,0.6142434929050139,1.0,7/27,6.99%,PER3;USP11;NEK6;EHMT2;RORA;PER2;LCOR
prerank,sterol transfer activity (GO:0120015),0.5743330066977947,1.2994490698575456,0.1813285457809695,0.7257946821198206,1.0,3/17,4.02%,PLTP;OSBP;ABCG1
prerank,protein phosphatase binding (GO:0019903),0.41054870669409527,1.296106638654108,0.09504685408299866,0.7293668099533493,1.0,15/117,5.16%,MFHAS1;PPP1R16B;DAB2IP;ITGA1;FLT4;CTTNBP2NL;PTK2;FOXO1;JAK3;PXN;PPP1R9B;SNX3;CTNNB1;STRN4;KCNQ1
prerank,pseudouridine synthase activity (GO:0009982),-0.5419181459982148,-1.2945330789005411,0.16071428571428573,0.6242114100284888,1.0,6/13,28.26%,PUS7;PUS10;RPUSD4;RPUSD1;RPUSD2;RPUSD3
prerank,lipase activator activity (GO:0060229),-0.5886382540128692,-1.2933893748911716,0.17062634989200864,0.6176523223880808,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,ribosomal large subunit binding (GO:0043023),-0.5864489709399845,-1.2930831208447213,0.17555555555555555,0.6089146756571259,1.0,1/11,2.18%,CPEB2
prerank,adenylyltransferase activity (GO:0070566),0.5501696233404535,1.2901285743790967,0.168141592920354,0.7416383926901063,1.0,5/21,10.15%,TENT4A;MTPAP;GPHN;FICD;OASL
prerank,"DNA binding, bending (GO:0008301)",0.5909536837248879,1.2896345884551965,0.1923743500866551,0.7351845805395697,1.0,2/14,4.35%,LEF1;HHEX
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6024664366195409,1.287836660863693,0.19525547445255476,0.733304784002884,1.0,4/13,2.62%,PDGFB;PDGFD;IL1R1;PTPRJ
prerank,manganese ion binding (GO:0030145),-0.4020467230220052,-1.2877109601853804,0.12215909090909091,0.6149842255538892,1.0,16/48,23.55%,MPPED2;LARGE1;ME1;ADCY2;TDP2;SOD2;B4GALT1;FAM20C;ABL1;DYRK2;PPM1M;PRIMPOL;XPNPEP3;WRN;ATP13A2;GALNT1
prerank,kinase inhibitor activity (GO:0019210),-0.4427586366471519,-1.283068514990789,0.14720812182741116,0.6194590547370232,1.0,15/33,28.76%,PARVA;GMFB;QARS1;DUS2;LRP6;DNAJC3;CDKN1C;MAPK8IP1;SMCR8;RHOH;SOCS3;TAOK3;TRIB1;AHSG;DUSP19
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5288994634220144,-1.283067395463671,0.18259023354564755,0.6102133972036348,1.0,3/14,2.07%,FHIT;ENPP1;NUDT4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6078524698852696,1.2811717598579972,0.19444444444444445,0.748407101336126,1.0,2/12,5.11%,TENT4A;MTPAP
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4846445716775201,1.2785387366755192,0.15873015873015872,0.7503459506509093,1.0,7/38,7.17%,HIP1;DAB2IP;PARD3;SNX13;SNX3;TECPR1;PLEKHA5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.47256028045625753,1.2722142080789298,0.1592356687898089,0.7640024834600768,1.0,14/42,11.85%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;FBXW7;YES1;HCK;PIN1;SHC3;PTPN5;SHB;SHF;SYK
prerank,MHC class II protein complex binding (GO:0023026),0.6218942067888406,1.2689104971497729,0.22862453531598512,0.7672444515055661,1.0,4/11,10.71%,HSP90AB1;CD4;PKM;HSPA8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.5658590292574596,-1.2677369635034461,0.18421052631578946,0.6449844672885571,1.0,5/11,12.49%,AMFR;UBR5;UBE4B;PPIL2;PRPF19
prerank,hexosyltransferase activity (GO:0016758),0.40952517786411735,1.2667662457538167,0.1093969144460028,0.7667656677220483,1.0,10/101,7.21%,TMTC2;CSGALNACT1;GBE1;B4GALT5;B4GALT4;MFNG;B3GNT2;FUT9;PIGM;GCNT7
prerank,GTPase binding (GO:0051020),0.37508647418396684,1.2606975718643898,0.09821428571428571,0.7795782983169537,1.0,36/194,13.05%,DOCK4;FGD5;SPTBN1;SRGAP2;RASIP1;SH3BP4;CAV1;FNBP1L;UNC13B;ARHGEF2;RIN3;YBX1;PEX5L;EPS8;USP6NL;PKN1;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;GNB1;CYRIB;RANBP9;TMEM127;FGD2
prerank,epidermal growth factor receptor binding (GO:0005154),0.5058949164993926,1.2599000537076277,0.19370860927152317,0.7741869475982015,1.0,6/25,12.17%,HIP1;GRB2;CCDC88A;TGFA;CNOT9;TNK2
prerank,vinculin binding (GO:0017166),0.6129279325345589,1.2574852149962048,0.24862888482632542,0.7745799999083797,1.0,5/11,9.38%,UTRN;CORO2B;PXN;ACTN1;SYNM
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.45014738717657365,1.2554664938954114,0.17429837518463812,0.7736042342575592,1.0,6/53,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC43A2;SLC1A2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5221776094804702,1.2503492989674974,0.19326241134751773,0.7825612910798041,1.0,5/23,10.68%,HIP1;HIP1R;SNX3;PLEKHA5;CLVS2
prerank,transmitter-gated ion channel activity (GO:0022824),0.49351891006443444,1.2479320259121454,0.1967479674796748,0.7827077076391951,1.0,17/29,25.87%,GRID2;CHRNB1;GABRB1;GRIA4;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GRIA2;GRIK3;GABRA2;GRID1;GABRG2
prerank,PDZ domain binding (GO:0030165),0.43576618859988775,1.24720200250918,0.16208393632416787,0.7776678411692826,1.0,16/61,10.76%,DOCK4;USHBP1;CADM1;RAPGEF2;F11R;FZD4;ACOX1;GRID2;PLEKHA1;ATP2B1;SLC9A3;TMEM88;TMEM88B;CLCN3;ADAM17;CRIPT
prerank,sulfotransferase activity (GO:0008146),-0.432010989589291,-1.2466853456920386,0.1501416430594901,0.6986880467647976,1.0,9/33,15.23%,UST;HS3ST3A1;HS2ST1;CHST15;HS6ST1;CHST8;CHST3;CHST1;GAL3ST2
prerank,phospholipase activator activity (GO:0016004),-0.5600388175013743,-1.246667228593932,0.208955223880597,0.6887350906156672,1.0,2/10,9.06%,ARHGAP6;PDPK1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4136885217306952,-1.2450300554406963,0.1575,0.6842803691876164,1.0,13/33,25.66%,AR;CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4;TBP;WAC;UVSSA;SMYD2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5855041165670337,-1.244097982168658,0.22247706422018348,0.6771978395691506,1.0,9/10,41.23%,DSE;RENBP;GALE;FUOM;DSEL;GFUS;GLCE;GALM;GNE
prerank,store-operated calcium channel activity (GO:0015279),-0.5803990562552708,-1.2440331483449596,0.2129032258064516,0.6681111268939514,1.0,4/10,13.12%,TRPC3;TRPC6;TRPC4;ORAI2
prerank,disordered domain specific binding (GO:0097718),0.5112552968445951,1.2414147766330617,0.23620689655172414,0.789797250002966,1.0,4/23,9.03%,CALM1;HSP90AB1;FYN;DFFB
prerank,nuclear export signal receptor activity (GO:0005049),-0.535827129336492,-1.2410151229779116,0.22736842105263158,0.6677834468797017,1.0,4/11,16.48%,RANBP17;XPO5;XPO6;XPO1
prerank,protein phosphatase 1 binding (GO:0008157),0.5165999183569019,1.2407711867310882,0.23361344537815126,0.784794731469319,1.0,5/21,9.53%,PPP1R16B;PPP1R9B;KCNQ1;PHACTR4;PPP1R11
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.47577474385623436,1.2405398848604676,0.2026359143327842,0.7783292183999257,1.0,4/33,3.78%,RNF144B;DCUN1D3;FOXL2;RNF125
prerank,cytokine activity (GO:0005125),-0.32317943070417016,-1.2400849884104752,0.07112970711297072,0.6613362518317906,1.0,14/131,4.69%,BMP6;IL34;WNT4;BMP5;BMP7;WNT5B;BMP4;WNT6;IL18;WNT9A;IL16;CXCL16;TNFRSF11B;FGF2
prerank,nuclear receptor coactivator activity (GO:0030374),0.4478683468156371,1.2393297923415012,0.17055393586005832,0.7752404269220684,1.0,14/52,13.23%,ETS1;NCOA1;PKN1;ACTN4;ACTN1;BUD31;NCOA2;TACC1;HMGA1;CNOT9;HELZ2;PRKCB;CNOT6;PSMC3IP
prerank,protein homodimerization activity (GO:0042803),0.3466333633475108,1.239188799997979,0.035106382978723406,0.7686226395355483,1.0,101/589,12.47%,TFRC;ABCG2;HIP1;PECAM1;PDGFB;SRGAP2;CADM1;BCL2L1;DAB2IP;SYNE1;RASIP1;TGFB2;PDE2A;ZHX3;XDH;TBX1;TPD52;IL6R;FLT4;HIP1R;GCH1;TPD52L1;TRIM14;B2M;F11R;FZD4;NOD1;LRRFIP1;TBC1D22A;KLHL7;DEFA6;GBP4;STK10;DSCAML1;GBP5;VIL1;ZBTB16;ABCG1;IKBKB;HHEX;SARS1;NOS2;HSP90AB1;MTPAP;CD4;CAT;ACOX1;INPP5F;CCDC88A;GSTA4;TPST2;ACTN4;ADAM10;TOX3;MCL1;STAT1;ACTN1;YARS2;FICD;BST2;ACSL6;KCNH2;ST6GAL1;SHMT2;KCNN2;MKLN1;CST7;TERF2;CPOX;FOXP3;PDXK;PRDM9;CAV2;IRAK2;GREM1;RAB11FIP4;BNIP3L;SNRPC;GLB1;CBS;HPGDS;BANF1;COQ9;CNOT9;PDCD10;TIMM10;HSPB1;HOOK1;ABCD1;TPM4;RBPMS;MMAA;SLK;SH3GLB1;MID1;PIP4K2A;CEACAM1;NAA60;GDF15;PANK3;TERF1
prerank,growth factor receptor binding (GO:0070851),0.4021258234315845,1.237679258883692,0.15163934426229508,0.7669005090793893,1.0,17/95,12.20%,HIP1;PDGFB;PDGFD;IL1R1;IL6R;PTPRJ;GRB2;FGF16;CCDC88A;FYN;TGFA;PGF;ADAM17;CNOT9;CNTF;TNK2;IL27RA
prerank,LRR domain binding (GO:0030275),-0.5145067491932661,-1.2361529030239087,0.22706422018348624,0.6646123926187504,1.0,2/14,0.50%,ROBO1;PAWR
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4429936768042133,-1.231283444196738,0.18632075471698112,0.6708522996786552,1.0,8/27,10.27%,SLC41A1;SLC8A3;SLC9A2;SLC8B1;SLC9B2;SLC8A1;SLC9A9;SLC9A1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.4679053818847022,1.2301327076608266,0.20165289256198346,0.7845484266240931,1.0,6/34,5.11%,ARAP3;MYO10;ARAP2;HIP1R;PARD3;CYTH3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.45759328130466354,-1.2292656960159614,0.19483568075117372,0.6682076776105602,1.0,6/20,15.29%,MOGAT3;AGPAT4;LPGAT1;LCLAT1;GPAT3;PNPLA3
prerank,ionotropic glutamate receptor binding (GO:0035255),0.5952274186071771,1.2288574976228128,0.24555160142348753,0.7817365105692111,1.0,3/10,13.53%,SHANK3;SHISA6;IGSF11
prerank,phosphotyrosine residue binding (GO:0001784),0.46381597904737404,1.2285489073503066,0.21035598705501618,0.7758675615614827,1.0,12/37,11.85%,SHE;BCAR3;PIK3R3;ZAP70;GRB2;YES1;HCK;SHC3;PTPN5;SHB;SHF;SYK
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.41659559623623543,1.2265713223393295,0.16931982633863965,0.7758132308725517,1.0,14/72,10.17%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;KCNQ1;SYT7;FCHO2;TWF2;CAPG;AMER2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.46062781189361146,-1.2263461036800767,0.21553884711779447,0.6681753663170307,1.0,11/20,28.73%,EHMT2;SETD7;SETD4;EEF2KMT;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.577886773046188,1.2258782733642293,0.25,0.7714668273579337,1.0,1/11,1.89%,DDAH1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.36026062132317993,1.2242239859149513,0.10705882352941176,0.7701784426701677,1.0,31/254,8.56%,LEF1;MECOM;ETS1;ERG;ELK3;ZIC3;SOX17;KLF7;MEF2C;FOXO1;ZBTB16;PRDM2;IRF2;HHEX;FOXF1;RREB1;CREB1;KLF4;NKX2-8;NR1H2;GTF2I;IRF5;SOX18;NFIC;SOX12;HINFP;JUN;ATF6B;TCF12;KLF6;ELK4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5110471280076804,1.223604197940135,0.2413793103448276,0.7655101204081342,1.0,4/25,6.22%,HIP1;ARAP3;HIP1R;PLEKHA1
prerank,protein kinase binding (GO:0019901),0.3438308662492466,1.222831043938609,0.06825568797399784,0.7615458611817862,1.0,90/479,12.53%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;BMPR2;MAP4K2;CAV1;TJP2;TIRAP;GCH1;NEDD9;TRIM14;STK38;TBC1D14;PTPRJ;RGCC;PTK2;IFNAR2;DUSP7;ACVRL1;NOD2;MAP3K1;PRKD2;HDAC9;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;HINT1;CEP68;KCNQ1;CD4;RHOB;PKN1;EPHA4;CCDC88A;TSKS;ADAM10;RFFL;ADCY4;CDKN2B;IRF5;PTPRR;SPAG9;PRKAR2B;LRBA;PIN1;TWF2;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;CAVIN2;PPP1CB;CCND3;PRKAR2A;TRIB2;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;HSPB1;FERMT2;DUSP1;EXOC2;RAC1;PRKCB;ADIPOR1;GSK3A;HIF1A;RND1;CEACAM1;CCNK;RPTOR;DUSP16;MAPRE3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5869374372525278,1.221509016870804,0.25693160813308685,0.7595675299458622,1.0,6/10,22.25%,ATXN3;CYLD;TNFAIP3;OTUD4;DESI2;STAMBP
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3618411946178249,1.2210123719290342,0.10513739545997611,0.7547950130652262,1.0,41/248,13.02%,DNM3;MYO1E;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MYO6;MTG1;KIF26A;GNA12;RHOB;EFTUD2;TBC1D24;ABCA3;KIF2A;ATP2B1;KIF1A;RALB;DNM2;RAB11A;RAP1B;PIN1;IRGM;GTPBP1;GPN3;DNA2;GFM1;RAB3B;ABCD1;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5083541499830658,1.2180791015586658,0.225752508361204,0.7577119934434787,1.0,6/23,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4019431989623935,1.2131883881950265,0.17604617604617603,0.7670921670600483,1.0,18/91,10.68%,PLCB1;FLII;HIP1;TIRAP;HIP1R;PARD3;STXBP6;VIL1;SNX3;KCNQ1;SYT7;PIRT;PLEKHA5;FCHO2;TWF2;CAPG;AMER2;CLVS2
prerank,5'-3' exonuclease activity (GO:0008409),0.5573593776929346,1.2124677438633753,0.2361111111111111,0.7631208474788377,1.0,9/14,21.81%,MRE11;DCP2;DXO;FAN1;TRIR;EXOG;XRN1;XRN2;DCLRE1C
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.37646172791185417,-1.210870510236634,0.16976127320954906,0.7055993433378471,1.0,6/46,4.19%,B3GALT1;LARGE1;EXT1;MGAT3;MGAT4C;OGT
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.2671210621459893,-1.2079714578367988,0.0,0.7056809726679322,1.0,129/731,13.14%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;CREB3L1;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1;GATA6;ZNF697;ZNF182;ZBTB38;NR2F1;ZNF148;PRMT5;ETV1;TFCP2L1;RXRA;ESR1;PGR;ZNF219;HOXB5;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5
prerank,water transmembrane transporter activity (GO:0005372),0.5869254282043582,1.2051633471765857,0.287593984962406,0.7800018507313947,1.0,2/11,4.59%,AQP11;AQP7
prerank,CoA-ligase activity (GO:0016405),-0.5004445219942191,-1.2033962527335138,0.2413793103448276,0.7107254818304922,1.0,4/14,15.55%,ACSL1;ACSS3;AACS;ACSS1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40727719288448977,1.2025460522441722,0.2002820874471086,0.7819714507545948,1.0,8/71,5.14%,PTPRG;PTPRM;PTPRB;PTPRJ;DUSP23;PTPN12;DUSP3;CDC14A
prerank,aminopeptidase activity (GO:0004177),-0.4233079678143878,-1.2023326599360267,0.21608040201005024,0.7052893463706241,1.0,5/26,8.24%,MMP14;MMP16;ANPEP;ENPEP;NPEPPS
prerank,R-SMAD binding (GO:0070412),-0.4784956773850453,-1.2016831273119701,0.2235294117647059,0.6990864234172401,1.0,4/18,2.35%,LDLRAD4;SMAD3;DDX5;SMAD6
prerank,kinase binding (GO:0019900),0.34009958597160755,1.2010231082199578,0.08287895310796074,0.7804007806850601,1.0,82/434,12.68%,TFRC;FRMD5;UTRN;BCL2L1;DAB2IP;RHOBTB1;CAV1;FAS;PDE8A;BCAR3;TRIM14;TBC1D14;PTPRJ;RGCC;STX1A;PTK2;SP100;IFNAR2;ACVRL1;NOD2;TIAM1;PIK3IP1;MAP3K1;HDAC7;DUSP3;ACTB;PLCG1;IKBKB;CALM1;GRB2;CTNNB1;CEP68;HSP90AB1;CD4;RHOB;TTC28;TSKS;ATP1A4;ADAM10;RFFL;PPP2R5A;CDKN2B;IRF5;PTPRR;CD160;LRBA;IRGM;FAM83G;ACSL3;IQGAP1;RPS7;PTN;CAV2;ARHGEF7;SHC3;CDK5RAP2;MSN;PPP1CB;CCND3;CNOT9;BTG1;GRB7;DCX;PDCD10;SMAD1;NBEAL2;PRKAB1;TOLLIP;CDC6;HSPB1;FERMT2;EXOC2;UBQLN1;RAC1;ADIPOR1;HIF1A;RND1;CEACAM1;CCNK;RPTOR;MAPRE3;WWC1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5762599762188667,1.1994566763663803,0.2872727272727273,0.7792554958417862,1.0,2/13,1.98%,SLC7A1;SLC38A5
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.26458889749187203,-1.199258457855862,0.0,0.697609326392079,1.0,112/732,11.02%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;SIX1;TBX18;EBF4;IKZF4;BCL6;TEAD3;CHD2;HEYL;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1;GATA6;ZNF697;ZNF182;ZBTB38;NR2F1;ZNF148
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5602733039089096,-1.197504502703666,0.2540650406504065,0.6946692250981089,1.0,5/10,11.17%,SLC24A3;SLC8A3;SLC8B1;SLC8A1;SLC24A5
prerank,calcium-release channel activity (GO:0015278),-0.46671246480175793,-1.196179294826856,0.22566371681415928,0.6903621108624304,1.0,5/17,13.36%,ITPR1;PKD2;RASA3;ITPR2;TPCN1
prerank,adenylate cyclase binding (GO:0008179),-0.5401502195861414,-1.1958777670722818,0.27973568281938327,0.683395081610593,1.0,3/10,4.15%,ADCY5;AKAP12;ADCY2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.49197266055158495,1.1935901706427616,0.2591304347826087,0.7907541417748168,1.0,6/24,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,cytokine receptor binding (GO:0005126),0.3985022578925376,1.193222148767668,0.18838526912181303,0.7859018802080339,1.0,16/83,13.42%,KITLG;TGFB2;CXCL12;IL6R;PXDN;SOCS2;OSMR;PGF;LIFR;ADAM17;CNTF;TNFSF11;SYK;IL27RA;DDT;SDCBP
prerank,FMN binding (GO:0010181),0.5716469051102582,1.191581197971363,0.275,0.7851017752839331,1.0,2/11,4.51%,NOS3;NOS2
prerank,CXCR chemokine receptor binding (GO:0045236),0.5735397462249061,1.1886583819964311,0.28680688336520077,0.7875300680938294,1.0,1/11,1.41%,CXCL12
prerank,amino acid binding (GO:0016597),0.46743334342544207,1.188500036432605,0.24539877300613497,0.7820626413883233,1.0,10/31,20.55%,NOS3;DDAH1;NOS2;GRIN3B;SHMT2;GRIN2B;GRM7;GLRA2;AGXT;ASS1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.44910235030049883,1.186412107335108,0.24193548387096775,0.782668003187961,1.0,10/35,12.17%,FES;PTK2;ZAP70;LYN;FYN;YES1;HCK;PTK6;SYK;TNK2
prerank,acid-thiol ligase activity (GO:0016878),-0.5008682668559072,-1.1833230358643527,0.2735632183908046,0.711699345192825,1.0,4/13,15.55%,ACSL1;ACSS3;AACS;ACSS1
prerank,hormone receptor binding (GO:0051427),0.5415433130762028,1.182678257587858,0.26353790613718414,0.7881753554814735,1.0,2/14,4.86%,SOCS2;NPPA
prerank,cholesterol transfer activity (GO:0120020),0.5257390733115629,1.1822819205054833,0.29443447037701975,0.7835635232845319,1.0,2/16,4.02%,PLTP;ABCG1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5023997222855414,-1.1809233119006264,0.24780701754385964,0.7107034694268737,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,alpha-tubulin binding (GO:0043014),0.4661855255046038,1.1792655926958946,0.2626427406199021,0.787052639244979,1.0,5/31,8.53%,TTLL7;EFHC2;DIP2B;FYN;TRIM36
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5743843478613148,1.1791056262931874,0.2722222222222222,0.7819398601704001,1.0,4/10,12.15%,PIK3R3;PIK3C3;PIK3C2A;PIK3CB
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.43996544607950405,-1.1742272959996842,0.2518891687657431,0.7226829339389395,1.0,4/23,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,phosphoric diester hydrolase activity (GO:0008081),0.45419509592712315,1.1716701482126752,0.26881720430107525,0.7985847589145824,1.0,4/35,5.89%,GPCPD1;PLCB4;PLD4;GDPD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.5320574865468057,-1.1704790039588746,0.29010989010989013,0.7253685155418914,1.0,1/10,0.41%,DPYSL3
prerank,hyaluronic acid binding (GO:0005540),0.5674527100775416,1.1671600547179863,0.31401869158878504,0.806720798865156,1.0,2/10,5.07%,LAYN;HYAL2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4477294658666935,-1.1645774176976216,0.26405867970660146,0.7339077381896254,1.0,4/21,2.52%,PDE1A;PDE5A;PDE3A;PDE8B
prerank,TBP-class protein binding (GO:0017025),0.4887124902059589,1.1644735575294785,0.273972602739726,0.8090904937479759,1.0,6/21,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5747544131308379,1.1632166384567695,0.32741617357001973,0.801939401903811,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5747544131308379,1.1632166384567695,0.32741617357001973,0.801939401903811,1.0,5/10,20.82%,DUSP7;DUSP1;DUSP16;DUSP8;DUSP6
prerank,SUMO transferase activity (GO:0019789),-0.46028611830468463,-1.1627014571954055,0.28703703703703703,0.7319697930673557,1.0,5/16,18.80%,HDAC4;PIAS1;PIAS2;NSMCE2;MUL1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5520850699315794,1.1604529836186548,0.3183453237410072,0.8045654010774843,1.0,5/12,8.10%,PDE2A;PDE8A;PDE4D;PDE7B;PDE4B
prerank,O-acyltransferase activity (GO:0008374),0.45306298322499083,1.1584416155474524,0.29516129032258065,0.8054969504250259,1.0,16/30,25.85%,MBOAT1;AWAT2;LPCAT3;PRDX6;LRAT;MOGAT2;DGAT1;MBOAT7;LPCAT2;MBOAT2;LPCAT4;DGAT2;GPAT4;GPAM;PLAAT1;LPCAT1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5227411624113159,-1.1544377223045172,0.3051948051948052,0.7474334819593642,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5223469195070493,1.1532833988138227,0.31881533101045295,0.8158077293550735,1.0,1/14,0.03%,SPOCK2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2534890993831675,-1.1525947232639056,0.0,0.7451886512456176,1.0,116/831,10.10%,FOXP2;PBX1;SOX5;MAF;ZIC1;NFIA;ZEB2;NR2F2;ZIC4;AEBP1;GLI3;ZBTB7C;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;HOXC4;HOXC6;ARNT2;OSR1;HOXB3;TEAD1;NR6A1;HOXA3;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;MXI1;TOP1;IKZF2;HOXB4;PRRX2;TEF;SALL1;NR1D2;HOXB6;FOXC2;DNMT3A;FOXC1;TBX15;KCNIP3;HIVEP2;MLXIP;PLAGL1;RBPJ;ZNF423;HOXA7;MKX;ZNF367;RORA;AR;GLIS2;PPARA;PBX4;HIF3A;RUNX2;KLF3;PURG;SIX1;TBX18;EBF4;ZNF25;IKZF4;BCL6;TEAD3;NFXL1;CHD2;HEYL;HOXC8;NR3C2;MEIS1;PBX3;GLI1;ZEB1;SMAD9;ZFAT;ZNF568;FOXJ2;NFATC4;ATF5;EBF2;ELF4;ZSCAN29;KLF15;RFX7;MITF;FOXL1;KDM6B;POU6F1;RBAK;HSF2;ATOH8;STAT5A;ZNF23;FOXO3;SOX6;MGA;TWIST2;ZNF483;ZKSCAN7;ARNT;CEBPB;ELK1
prerank,mechanosensitive ion channel activity (GO:0008381),0.5445672179366762,1.1511107532693545,0.322265625,0.8168349087389758,1.0,4/12,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,protein phosphatase inhibitor activity (GO:0004864),0.463677056911717,1.150157162314643,0.29475308641975306,0.8141775259261113,1.0,13/26,26.12%,PPP1R9B;PPP1R2;PTN;PPP1R11;PPP1R14C;PPP1R8;BOD1;PPME1;SET;ENSA;PABIR1;LMTK2;PPP1R14A
prerank,protein phosphatase regulator activity (GO:0019888),0.4062433070157532,1.148970013909539,0.27341389728096677,0.812163487005985,1.0,14/53,16.89%,PPP1R16B;PPP1R9B;CALM1;PPP4R1;PPP1R2;PPP2R5A;PTN;PHACTR4;PPP1R15B;B3GAT3;PPP2R2C;BOD1;PPME1;SHOC2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4973823485319351,-1.1476664959887872,0.2817204301075269,0.7518744933472271,1.0,6/12,6.60%,IGF1;IRS1;SHC1;ARRB1;IGF2;GNAS
prerank,BMP binding (GO:0036122),0.5499929159010358,1.1442469742761923,0.31851851851851853,0.8209006734605909,1.0,2/11,1.29%,ENG;BMPR2
prerank,galactosyltransferase activity (GO:0008378),0.5398683801962685,1.1439954901442189,0.3435700575815739,0.8162237709932817,1.0,2/11,2.42%,B4GALT5;B4GALT4
prerank,lysophospholipase activity (GO:0004622),0.4936735676209871,1.1404089315291364,0.30272108843537415,0.8214967072091733,1.0,5/20,8.87%,PLA2G4B;PNPLA6;GDPD1;ENPP2;LYPLA1
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.33428063766541954,-1.1400371590554912,0.23529411764705882,0.766156308003548,1.0,13/60,11.28%,CTDSPL;PPM1E;LRRK1;CDC14B;PHLPP2;PPM1D;MTMR3;PPM1B;CTDSPL2;PPEF2;PPP1R3C;LRRK2;PPP3CB
prerank,I-SMAD binding (GO:0070411),-0.4793192725478585,-1.1307222398481596,0.30155210643015523,0.7862830572507992,1.0,6/13,9.16%,SMAD3;SMAD6;TGFBR1;SMAD9;TGFB1I1;AXIN1
prerank,microtubule motor activity (GO:0003777),0.4088373211690641,1.1302193649446264,0.29983792544570503,0.8466242257700002,1.0,9/51,12.40%,STARD9;KIFC3;DNAH3;KIF26A;KIF2A;KIF1A;KIF3B;KIF23;DNAH8
prerank,guanyl ribonucleotide binding (GO:0032561),0.34105865765372845,1.129237823684887,0.24257425742574257,0.8443799595310434,1.0,31/196,11.99%,MFHAS1;INSR;RHOBTB1;PDE2A;RAPGEF2;GCH1;RAB31;GBP7;GBP4;GBP5;CNGA2;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;RAB3B;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,GTPase activity (GO:0003924),0.3410310127049166,1.1272467616280197,0.231990231990232,0.8449036727986495,1.0,31/192,13.02%,DNM3;RHOBTB1;GCH1;RAB31;GNAI2;GBP7;GBP4;GBP5;GNAQ;MTG1;GNA12;RHOB;EFTUD2;TBC1D24;RALB;DNM2;RAB11A;RAP1B;IRGM;GTPBP1;GPN3;GFM1;RAB3B;RAC1;HRAS;MMAA;RAB4A;RND1;GNB1;GPN2;RAB1A
prerank,phospholipase C activity (GO:0004629),0.46275864544756967,1.1268899284316574,0.3137254901960784,0.8404807642875763,1.0,6/25,11.57%,PLCB1;PLCB4;PLCG1;PLCH2;CHRM3;PLCH1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5285395408325516,1.126683323416239,0.3302238805970149,0.8357233173188998,1.0,2/11,12.88%,CNGA2;HCN2
prerank,tubulin binding (GO:0015631),0.3259423792036621,1.1266387408177456,0.2256586483390607,0.8305740105592607,1.0,54/295,12.61%,DNM3;TTLL7;MTUS1;EFHC2;REEP1;STARD9;ARHGEF2;MAP4;FGF13;DIP2B;CCDC69;STMN1;KIF26A;CLIP1;TTLL5;MAPRE2;RP1;CCDC88A;FYN;CCDC88B;KIF2A;KIF1A;STMN3;DNM2;RAB11A;STMN4;MAP6D1;BRCA2;MARK4;EML5;MAP1LC3B;ARHGEF7;TRIM36;CDK5RAP2;AGBL5;EML6;PAK1;RITA1;DCX;HAUS6;KIF3B;CCT5;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.48318326644791426,-1.1256678681802703,0.3333333333333333,0.7934568995900497,1.0,2/11,3.35%,EGFR;MAP3K5
prerank,cholesterol binding (GO:0015485),0.41640529210418065,1.12367743038205,0.30048465266558966,0.8341578578970471,1.0,6/47,8.94%,PROM1;CAV1;OSBPL1A;ABCG1;OSBPL10;NPC1
prerank,microtubule binding (GO:0008017),0.33500126620170784,1.1236239557745205,0.2284325637910085,0.8290952770758444,1.0,40/222,12.61%,DNM3;MACF1;MTUS1;REEP1;STARD9;ARHGEF2;MAP4;FGF13;CCDC69;KIF26A;CLIP1;MAPRE2;RP1;CCDC88A;CCDC88B;KIF2A;KIF1A;DNM2;RAB11A;MAP6D1;MARK4;EML5;MAP1LC3B;CDK5RAP2;EML6;DCX;HAUS6;KIF3B;CRIPT;HOOK1;PEX14;S100A8;KIF23;MAP10;MID1;POLB;MAP4K4;TERF1;MAPRE3;EML1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5248917929816063,1.1220553686313883,0.36380255941499084,0.8285446505897087,1.0,3/13,9.68%,SH3BP4;CCDC88A;ARHGDIA
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.43573462434822424,-1.1190572216787584,0.32798165137614677,0.8057062791366971,1.0,5/17,13.10%,DPYD;BDH2;PTGR2;PECR;DECR1
prerank,ligand-gated ion channel activity (GO:0015276),0.43940611707181254,1.1184422029345864,0.29549248747913187,0.8337575984197014,1.0,9/30,13.65%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.3365166139425129,-1.1184157881853392,0.2774566473988439,0.7996037985581366,1.0,12/53,11.94%,MICAL3;DDO;MICAL2;AOX1;DPYD;POR;NOX4;PRODH;MTHFR;CRY2;KDM1A;AIFM2
prerank,small GTPase binding (GO:0031267),0.3390102094435068,1.118134457972474,0.25882352941176473,0.8294140231259907,1.0,31/169,13.05%,DOCK4;FGD5;SRGAP2;SH3BP4;CAV1;UNC13B;ARHGEF2;RIN3;PEX5L;EPS8;USP6NL;PKN1;OCRL;RAPGEF4;NCKAP1;UNC13D;RAB34;IQGAP1;RAB11FIP4;PAK1;FGD6;BICDL1;CYFIP1;KIF3B;EXOC4;EXOC2;TBC1D30;CYRIB;RANBP9;TMEM127;FGD2
prerank,ligand-gated channel activity (GO:0022834),0.44345218779217543,1.1173237943109329,0.2991596638655462,0.8266754168413664,1.0,9/29,13.65%,GRID2;CHRNB1;GRIN3B;GABRB1;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5085071375881047,1.1148879422385582,0.3648881239242685,0.8287075330304144,1.0,2/14,2.77%,MAL;NOD1
prerank,glucuronosyltransferase activity (GO:0015020),0.4768643219789677,1.114592820196019,0.35008665511265163,0.8245456038482863,1.0,1/19,0.34%,CSGALNACT1
prerank,copper ion binding (GO:0005507),-0.3622878553288851,-1.1135546771731586,0.2837465564738292,0.8053237863807527,1.0,7/42,7.23%,MOXD1;LOXL3;PAM;SOD3;LACC1;ATP7A;P2RX4
prerank,lipase activity (GO:0016298),0.4088804493550987,1.1110066749456025,0.32857142857142857,0.830156549910465,1.0,5/43,12.54%,ABHD2;LIPE;LYPLA1;LIPC;PNPLA8
prerank,lipid phosphatase activity (GO:0042577),0.5111783125688301,1.1107416161239065,0.35535714285714287,0.8260115891037342,1.0,2/14,3.82%,SGPP2;PLPP6
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.37507556634247324,-1.1077240255998693,0.3323529411764706,0.8142578590416614,1.0,14/32,20.23%,KDM7A;KDM2A;EGLN3;KDM2B;P4HTM;PHF8;TMLHE;PHYH;ALKBH1;BBOX1;RIOX2;JMJD4;HSPBAP1;TYW5
prerank,anion channel activity (GO:0005253),0.3871326557084625,1.1057603813593115,0.3150074294205052,0.8357144827734352,1.0,21/61,19.47%,LRRC8B;LRRC8C;CLCA2;GABRB1;CLCN3;CLIC4;GPR89A;GPR89B;TTYH3;GABRQ;LRRC8D;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,channel activity (GO:0015267),0.41334462879269646,1.104674004303619,0.33178294573643413,0.8339468242719374,1.0,4/41,7.08%,AQP11;MCUB;AQP7;CHRNB1
prerank,vitamin D receptor binding (GO:0042809),-0.4625345313895957,-1.1026816485235014,0.34988713318284426,0.8214179980549232,1.0,6/14,25.19%,MED14;RXRA;MED30;MED4;MED24;MED16
prerank,microtubule minus-end binding (GO:0051011),0.5080077446006007,1.1024784646069594,0.3521897810218978,0.8353768041526428,1.0,1/13,1.09%,MACF1
prerank,GTP binding (GO:0005525),0.33668972107003725,1.1000977284962579,0.29620253164556964,0.8375973268684647,1.0,27/172,11.99%,MFHAS1;INSR;RHOBTB1;GCH1;RAB31;GBP7;GBP4;GBP5;TGM2;ARF5;REM2;RHOB;RALB;DNM2;RAP1B;ADSS2;ARL4A;RAB39A;ARHGEF5;TUBB;EIF2B2;RAC1;HRAS;MMAA;RAB4A;TUBD1;RND1
prerank,RNA stem-loop binding (GO:0035613),-0.47116157482924864,-1.0988062285791313,0.36283185840707965,0.8254059513988806,1.0,4/12,14.89%,EPRS1;FMR1;DDX3X;LARP6
prerank,nucleotidyltransferase activity (GO:0016779),0.47256797119854654,1.098719689319483,0.3433333333333333,0.8365821596707744,1.0,2/19,5.11%,TENT4A;MTPAP
prerank,gated channel activity (GO:0022836),0.5039519603476614,1.0979648611722754,0.362453531598513,0.8340522576618465,1.0,4/14,5.69%,PIEZO1;TMEM63B;TMC5;TMC7
prerank,GABA receptor binding (GO:0050811),-0.5003491481289033,-1.097872441045563,0.35714285714285715,0.8207190968927734,1.0,6/11,26.58%,TRAK1;PLCL2;ARFGEF2;SHISA7;AKAP5;LHFPL4
prerank,sterol binding (GO:0032934),0.39224012718726886,1.0969522083592642,0.31627906976744186,0.8322756166138734,1.0,5/56,4.02%,PROM1;CAV1;OSBPL1A;OSBP;ABCG1
prerank,ATP hydrolysis activity (GO:0140603),0.4119717658027537,1.096385311012945,0.3281733746130031,0.8290558357896507,1.0,6/41,10.97%,MYO1E;KIF26A;ABCA3;ATP2B1;DNA2;ABCD1
prerank,calcium channel inhibitor activity (GO:0019855),0.5199366778900485,1.0911374285270468,0.3675675675675676,0.8392749170599271,1.0,3/11,4.35%,MCUB;SLC30A1;CALM1
prerank,translation initiation factor activity (GO:0003743),0.41589873673503114,1.0908164551139135,0.33083832335329344,0.8353342000472147,1.0,14/36,16.71%,EIF3F;EIF3E;EIF2B1;EIF3D;MTIF3;EIF2B2;EIF4E;EIF3B;EIF3G;EIF3L;EIF3M;EIF1B;COPS5;EIF4A1
prerank,protein kinase inhibitor activity (GO:0004860),-0.35281151744467637,-1.089424208726935,0.3062330623306233,0.8391219977699045,1.0,10/42,18.21%,PARVA;GMFB;SPRED1;QARS1;IBTK;DUS2;DNAJC3;CDKN1C;MAPK8IP1;SMCR8
prerank,ubiquitin-specific protease binding (GO:1990381),-0.4171504846885886,-1.0891514973621734,0.35141509433962265,0.832414188980717,1.0,6/19,13.57%,AMFR;LCOR;PRKN;SELENOS;SYVN1;PTEN
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.4526937452791367,1.0874239119485332,0.3554421768707483,0.8403682136286444,1.0,1/21,0.28%,POLK
prerank,receptor tyrosine kinase binding (GO:0030971),0.3838501828316966,1.0837355506697273,0.35030864197530864,0.8457487091675794,1.0,8/56,10.44%,GRB14;DOCK4;DUSP3;ELMO2;HYAL2;SHC3;SOCS5;ACP4
prerank,chloride transmembrane transporter activity (GO:0015108),0.4866447448716204,1.0808185153610352,0.3891992551210428,0.8492966781547561,1.0,1/16,0.40%,SLC1A1
prerank,transcription coregulator binding (GO:0001221),-0.339213015396741,-1.0802345369296473,0.3180428134556575,0.8517539489948549,1.0,15/50,12.24%,SMAD3;THRB;PER3;CCNT2;USP11;NEK6;EHMT2;RORA;AR;PER2;LCOR;MED25;VGLL4;ESR1;PGR
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.47354424390045363,1.0797200687880588,0.3810344827586207,0.8477588823960323,1.0,12/19,25.87%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.358159671831526,-1.0772898407372875,0.33506493506493507,0.8528973500388292,1.0,13/33,25.66%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;SPTY2D1;ELP4;WAC;UVSSA;ERBB2;SMYD2
prerank,methyl-CpG binding (GO:0008327),-0.39809378015705654,-1.0768558176200635,0.34760705289672544,0.8464673272154397,1.0,15/22,35.88%,CXXC5;ZBTB38;PRMT5;CXXC4;ZBTB4;MBD2;ERH;TET1;ZCWPW1;UHRF1;MBD3;MBD1;LRWD1;PRMT1;LHX4
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5113416993644371,1.076710652905132,0.4059040590405904,0.8516254222864287,1.0,4/11,17.21%,KCNQ1;KCNH2;KCNJ3;KCNJ5
prerank,G protein-coupled receptor activity (GO:0004930),0.3211811218811784,1.0747077057838952,0.31738623103850644,0.8525302355762361,1.0,38/239,17.02%,ADGRL4;ADGRE5;ADGRL2;ADGRL3;HCRTR1;S1PR1;ADGRG1;LPAR6;APLNR;CALCRL;CCR7;XPR1;OXTR;ADRA2B;GPR17;OPN5;HCRTR2;CXCR2;GPR52;GPR22;NPR1;AGTR2;CYSLTR1;ADCYAP1R1;TPRA1;MTNR1A;GPR171;GPR75;GPR85;OPN3;RXFP3;RXFP2;GPR62;OPRD1;GRM8;SSTR1;GLP1R;S1PR4
prerank,sequence-specific DNA binding (GO:0043565),-0.242101455095291,-1.0744334193685494,0.11864406779661017,0.8462610131100969,1.0,122/590,17.97%,FOXP2;PBX1;MAF;ZIC1;ZEB2;NR2F2;ZIC4;GLI3;RARB;ZBTB20;GLI2;CREB5;FOXD1;HLF;SMAD3;PKNOX2;HOXC4;ARNT2;OSR1;TEAD1;NR6A1;HOXA5;NFAT5;MEOX2;THRB;HDAC4;CUX1;HOXB4;PRRX2;TEF;NR1D2;HOXB6;FOXC2;FOXC1;TBX15;PPARGC1A;RBPJ;ZNF423;HOXA7;RORA;GLIS2;PPARA;PBX4;RUNX2;KLF3;SIX1;TBX18;BCL6;HOXC8;NR3C2;KDM2A;SIRT3;FOXJ2;NFATC4;ATF5;ELF4;ZSCAN29;BCL2;KLF15;VSX1;RFX7;FBXL19;KDM5B;FOXL1;KDM2B;POU6F1;HSF2;CREB3L1;ZNF23;FOXO3;CXXC5;ARNT;CEBPB;ELK1;GATA6;ZBTB38;NR2F1;ZNF148;PRMT5;CXXC4;ETV1;KDM1A;TFCP2L1;RXRA;ABL1;ESR1;XRCC5;HOXB5;FOXE1;SNAI1;SP3;ZBTB4;MAFB;MTF1;GZF1;HOXA9;ATF2;NR4A1;ZBTB7B;E2F3;RFX5;SREBF1;NFIB;MYBL2;FOXJ3;ZBTB26;SMG1;NR1H4;NFATC2;JDP2;HOXB2;HOXA6;MBD2;RARA;SIX4;HOXA2;HIC1;ZNF177;PAX2;CALCOCO1;FOXD2;BATF
prerank,DNA polymerase activity (GO:0034061),0.4446700365864195,1.0714084326017757,0.37777777777777777,0.8576397531460349,1.0,1/22,0.28%,POLK
prerank,carboxy-lyase activity (GO:0016831),0.42841386600914866,1.0688531846601181,0.3673139158576052,0.8600926922005857,1.0,1/23,0.61%,DDC
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.47237389338054037,1.0683388798542575,0.38644688644688646,0.8524250715038101,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.47237389338054037,1.0683388798542575,0.38644688644688646,0.8524250715038101,1.0,5/16,19.47%,TTYH2;CLCA2;TTYH3;ANO3;ANO5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.46817230328973203,-1.0670173210481906,0.3847826086956522,0.8611252295535069,1.0,7/12,23.80%,KDM7A;KDM3B;KDM1A;PHF8;PHF2;KDM4D;HR
prerank,translation elongation factor activity (GO:0003746),0.4986904686645471,1.0646265541327051,0.39718804920913886,0.8576239569156963,1.0,7/14,22.56%,GTPBP1;EIF5AL1;EIF5A;GFM1;EEFSEC;GTPBP2;EEF1B2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.45868819463687266,1.063821995051742,0.4070631970260223,0.8553922657660273,1.0,4/18,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,kinase activity (GO:0016301),0.34302223521852,1.06361839374152,0.35804195804195804,0.851440494010372,1.0,22/109,13.91%,ITPKB;DGKH;PRKD1;LYN;PRKD3;DGKI;EPHA4;DGKE;PKN2;CHKA;CERKL;PGM2L1;PDXK;PIK3C3;PIK3C2A;IPMK;DGKZ;PIK3CB;MAP4K4;PANK3;CERK;PSTK
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4957793276977099,1.0620164847500662,0.3988212180746562,0.8516116785896477,1.0,4/12,3.18%,ENG;LTBP4;BMPR2;ACVRL1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.4647746581463594,1.0620086592418827,0.40384615384615385,0.8472148207514272,1.0,9/17,24.02%,GRIN3B;GRIA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIA2;GRIK3;GRIN1
prerank,cAMP response element binding (GO:0035497),-0.47156696234692985,-1.0615946484079872,0.3905579399141631,0.8703216289608817,1.0,5/10,14.31%,CREB5;CREB3L2;CREB3L1;E4F1;ATF2
prerank,1-phosphatidylinositol binding (GO:0005545),0.47876598160550815,1.0609544356131062,0.4055045871559633,0.8456895338155361,1.0,3/15,7.28%,SCARB1;EPB41;WDFY3
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4114044242322827,1.060391676620476,0.3964401294498382,0.8430087587292984,1.0,11/33,20.62%,CNOT6L;NOCT;PDE12;PAN2;DCP2;CNOT6;DIS3L;EXOSC10;XRN1;EXOSC9;XRN2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.4442827500225585,-1.059678940902988,0.40898876404494383,0.8688049017469414,1.0,7/12,37.58%,AIFM2;NQO1;DCXR;CRYZ;DHRS4;CRYZL1;CBR1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.45724136729843984,-1.0584200479452552,0.422680412371134,0.8648080740050541,1.0,2/11,7.09%,ITPR1;RASA3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.26295881166896534,-1.0580131555286338,0.2962962962962963,0.8585453012311078,1.0,36/188,11.75%,BNC2;PBX1;SOX5;ZBTB20;SMAD3;SMAD6;HDAC4;GABPB2;PER3;CREB3L2;FOXC2;FOXC1;BCOR;TBL1XR1;AR;PER2;GLIS2;SIX1;TBX18;GLI1;ZNF568;ATF5;KLF15;CHD3;VSX1;YAP1;CREB3L1;FOXO3;SOX6;CEBPB;ELK1;GATA6;RNF10;CRY2;MTERF3;RXRA
prerank,iron ion binding (GO:0005506),-0.32929218636345486,-1.0545777268704821,0.34534534534534533,0.8613694007533081,1.0,18/48,28.86%,AGMO;AOX1;KDM7A;EGLN3;FXN;PHF8;PHYH;ALKBH1;FDX1;PHF2;TYW5;DNAJC24;FTL;TET1;ACO2;FBXL5;ACP5;SCD
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4339687361157949,-1.0539537547794355,0.4,0.8562054573447847,1.0,4/13,15.29%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,palmitoyltransferase activity (GO:0016409),0.42662008390416956,1.0511429212837473,0.3989547038327526,0.8645053978455104,1.0,6/28,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,cytokine receptor activity (GO:0004896),0.35517975238354144,1.0505427458680718,0.39777468706536856,0.8617665403397357,1.0,17/83,12.97%,IL1R1;IL6R;IFNAR1;FZD4;IFNAR2;IL10RB;OSMR;CD4;IL17RD;IL13RA2;IL4R;GPR17;LIFR;EBI3;IL20RB;IL27RA;IL7R
prerank,tropomyosin binding (GO:0005523),-0.4135239064104947,-1.0491411513651223,0.3977777777777778,0.8633901421572227,1.0,6/16,17.24%,CALD1;S100A6;LMOD1;TMOD3;TNNT3;TMOD2
prerank,GTPase inhibitor activity (GO:0005095),-0.4454392465059001,-1.0465232635360366,0.41721854304635764,0.8641970424355069,1.0,2/13,2.27%,CPEB2;SLIT2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4685821436884375,1.045342980570365,0.43416370106761565,0.8716511546279849,1.0,1/16,0.40%,SLC1A1
prerank,neuropeptide receptor binding (GO:0071855),0.47653877548957946,1.0432719115528648,0.40867992766726946,0.8726651849607626,1.0,3/14,18.55%,NPPA;PPY;NTS
prerank,histone deacetylase binding (GO:0042826),0.3440657415899626,1.039721257712762,0.4112676056338028,0.8780704938842818,1.0,9/88,8.41%,LEF1;MEF2C;HDAC9;HSP90AB1;TAL1;PKN1;PKN2;INSM1;FOXP3
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.46906738197820397,-1.0366306790905406,0.43820224719101125,0.8868475285134977,1.0,5/10,13.30%,CACNA1C;CACNA1D;CACNB4;CACNB2;CACNB1
prerank,N-acetyltransferase activity (GO:0008080),-0.39310014106812835,-1.035530673907182,0.41627906976744183,0.8831784626302748,1.0,12/19,37.84%,SAT1;NAA80;EP300;SAT2;NAT2;NAT8L;NAA50;AANAT;SMARCE1;ESCO1;NAT10;NAT1
prerank,WW domain binding (GO:0050699),0.4141825757656402,1.0352348585036006,0.42567567567567566,0.8860947779166595,1.0,6/26,18.20%,RAPGEF2;NDFIP2;TNK2;TCEAL6;TCEAL5;DAZAP2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.38168844576587097,-1.035085501120761,0.40632054176072235,0.877491891891892,1.0,3/22,4.90%,SCN7A;PKD2;CACNA1G
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4747939384711865,1.0348960944862267,0.4297945205479452,0.8825697774247653,1.0,2/15,5.02%,SLC1A1;SLC1A2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.40110803111765675,1.0341628954057454,0.40235690235690236,0.8800607653301462,1.0,19/35,30.31%,TAF1B;STAT1;RRN3;GTF2B;POU2F1;ZBTB17;NR3C1;UBTF;TAF4;TBPL1;FOXP1;TAF1C;MYC;SMARCA4;AGO1;SNAPC3;PARK7;TP53;DR1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4298404770472402,-1.0322382166747408,0.42951541850220265,0.8791046463661426,1.0,8/14,34.92%,ALDH4A1;MTHFR;MTHFD1;AASS;PYCR3;PYCR1;ALDH1L1;CRYM
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4468433549588585,1.0321771734857916,0.4300341296928328,0.8812158439914386,1.0,4/20,10.08%,TJP2;MAGI3;AK4;CMPK1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.357163067777286,-1.0308218211781695,0.42028985507246375,0.8764879806930402,1.0,7/27,21.73%,LRP1;APOE;HSP90B1;APBB3;AP2A1;SNX17;LANCL1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4191400589654471,1.0301998946997508,0.4307692307692308,0.8824676187111374,1.0,3/24,10.08%,ITPKB;AK4;CMPK1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3718250797102353,1.0295321869513399,0.4218009478672986,0.8799321536706,1.0,2/44,3.46%,MECOM;MEN1
prerank,protein kinase regulator activity (GO:0019887),-0.28961097066958835,-1.029418634191638,0.3920265780730897,0.873556218581313,1.0,23/95,16.02%,PRKAG2;PARVA;CCNT2;GPRC5C;GMFB;CCNL1;CCND2;QARS1;ELP3;STK11;CCNC;PRKAG3;CCNH;ANKRD54;STRADA;WNK1;DUS2;WNT11;CCNE2;ELP4;GPRC5A;DNAJC3;CDKN1C
prerank,nuclear receptor binding (GO:0016922),0.328563506532734,1.0274410539656105,0.42354533152909335,0.8810662532839278,1.0,18/111,12.54%,LEF1;NCOA1;CTNNB1;PKN1;ACTN4;STAT1;BUD31;NCOA2;TACC1;YWHAH;ARID1A;HMGA1;SRARP;OASL;PRKCB;ZBTB7A;HIF1A;GTF2B
prerank,ion channel activity (GO:0005216),-0.288100024017527,-1.0261426854833238,0.3958333333333333,0.8765748653954748,1.0,10/80,8.56%,TRPM3;NALCN;PIEZO2;PKD2;ABCC9;TRPM6;ANXA6;CALHM2;CALHM5;TRPC6
prerank,actinin binding (GO:0042805),0.43399866721592406,1.0241028219509707,0.4529616724738676,0.8861168680295278,1.0,2/21,2.01%,PROM1;MAGI1
prerank,syntaxin-1 binding (GO:0017075),0.43283486551302786,1.022649327719817,0.4468802698145025,0.8858530930016367,1.0,6/22,14.09%,UNC13B;SYPL1;STXBP1;SYNPR;CPLX1;SYPL2
prerank,RNA polymerase II complex binding (GO:0000993),-0.3451540671245815,-1.022394020567946,0.43073047858942065,0.8808805151701513,1.0,8/32,15.34%,CTR9;AGO2;PCF11;RPRD2;WDR43;URI1;PAF1;ELP4
prerank,voltage-gated anion channel activity (GO:0008308),-0.4209639483491612,-1.0194456292532361,0.44565217391304346,0.8827461148480498,1.0,4/15,9.40%,ANO6;CLCN2;ANO1;CLCN6
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3924179998656265,1.0182271439093478,0.42063492063492064,0.8937072081920286,1.0,10/34,20.62%,CNOT6L;NOCT;PAN3;PDE12;PAN2;CNOT6;DIS3L;EXOSC10;EXOSC9;XRN2
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.2375986986903098,-1.0180858652379376,0.4019607843137255,0.8797132035635811,1.0,77/346,17.69%,RNF220;PDZRN3;RNF152;PELI2;UBE2E2;RNF43;SH3RF3;CBLB;AMFR;BCOR;ASB2;TTC3;DTX4;DTX3;TRIM23;FBXO10;RNF145;FBXW8;DTX1;RNF217;UBE2R2;SH3RF2;TRAF3IP2;MGRN1;PRKN;PJA2;UBR5;UBE2E1;RNF214;SMURF2;RNF135;PML;UBE2M;LRSAM1;DDB2;CUL3;RNF31;KCMF1;BTRC;TRIM63;RNF10;KLHL13;HUWE1;NHLRC3;AKTIP;WWP2;MYLIP;RNF20;RNF181;NFX1;UBE2E3;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;FBXW11;RNF121;TRIM9;KLHL42;NSMCE1;TRIP12;RNF144A;UBE2B;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;UBR4;FBXO9;UBE2Q1;MEX3C
prerank,heme binding (GO:0020037),0.35413615756831934,1.0167816720263936,0.43805309734513276,0.8933432088486507,1.0,11/65,10.84%,NOS3;FLVCR2;CYP2E1;PXDN;NOS2;CYP11B1;CYP11A1;CAT;TBXAS1;CBS;CYBB
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4539273710834716,1.0153402163756522,0.4434931506849315,0.8928118067172058,1.0,5/15,12.15%,PIK3R3;PIKFYVE;PIK3C3;PIK3C2A;PIK3CB
prerank,ATPase regulator activity (GO:0060590),-0.33538537303922233,-1.0148581753680164,0.42896935933147634,0.8822968586578023,1.0,12/38,21.13%,FNIP1;SIL1;ATP1B3;ATP1B2;BAG1;TOR1AIP1;BAG3;ATP5IF1;DNAJB4;DNAJB2;TSC1;DNAJC24
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.3277089893136638,-1.013885309098955,0.42091152815013405,0.8786694437807439,1.0,6/38,6.75%,SERPING1;TFPI;ANXA2;SERPINH1;SERPIND1;SERPINF1
prerank,titin binding (GO:0031432),-0.4217546430921446,-1.011330468288531,0.43317972350230416,0.879270787602977,1.0,3/13,10.39%,ACTN2;CAMK2D;TRIM63
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.2481999779712014,-1.0110609325781241,0.40540540540540543,0.8735266292979563,1.0,51/232,16.51%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;PIAS1;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;PIAS2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,myosin binding (GO:0017022),-0.3064935181223841,-1.0108867077408252,0.42492917847025496,0.8676566471235048,1.0,5/55,3.47%,CALD1;KIRREL1;GSN;TRAK1;DMD
prerank,carboxylic acid binding (GO:0031406),0.376684748858288,1.0011339911914774,0.45023696682464454,0.9264670908956525,1.0,8/38,14.46%,NOS3;NOS2;SESN3;GRIN3B;SHMT2;GRIN2B;MAG;GRM7
prerank,chemokine binding (GO:0019956),-0.34627052490233917,-1.0006198273167333,0.42328042328042326,0.8902892716953771,1.0,4/30,10.36%,PDPN;CCR9;FGF2;ITGAV
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3598651644604345,0.9999418901729141,0.4675716440422323,0.9255085048602765,1.0,9/49,12.62%,ESYT2;DYSF;PLA2G4B;SYT7;CPNE8;ESYT1;CPNE5;SYT4;CPNE6
prerank,signal sequence binding (GO:0005048),0.38272565399457964,0.9997308137226962,0.47335423197492166,0.9217606448093855,1.0,10/35,19.37%,NFKBIA;PEX5L;CAT;AP2M1;RANBP6;AP2B1;TOMM20L;NUP153;KCNIP2;IPO4
prerank,metal ion binding (GO:0046872),0.2808579398739283,0.9993786535311742,0.48767416934619506,0.9183781757816946,1.0,79/477,14.18%,SPOCK2;CSGALNACT1;RASGRP3;ESYT2;LTBP4;PDE2A;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;STK38;SPARCL1;AGRN;SNRK;HPRT1;SNN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;NT5C3A;CDH8;MTPAP;CAMKK2;PIR;SYT7;PRKACB;ESYT1;RASGRP2;RET;IDH3A;DCHS1;CDH19;SRI;CRNN;CETN2;MAP3K6;IQGAP1;PDXK;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;NUDT3;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;DXO;CALB2;EML1;CPNE6;MAN1B1;CERK;STK3;CDH5;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;FAN1;HACL1;XYLT2;MOV10L1;PDCD6
prerank,ligand-gated calcium channel activity (GO:0099604),-0.37969251442347807,-0.998470732968532,0.4668141592920354,0.8899203040135181,1.0,4/19,10.59%,ITPR1;RASA3;P2RX4;TRPM4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4060682459880872,0.9967803791146364,0.4709897610921502,0.9207293123826515,1.0,5/26,13.25%,CSGALNACT1;B3GNT2;B3GALT4;B4GALNT1;B3GALT2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.39448214559948747,-0.9961488560140374,0.47404063205417607,0.890242922597075,1.0,4/15,15.29%,AGPAT4;LCLAT1;GPAT3;PNPLA3
prerank,ion channel inhibitor activity (GO:0008200),0.381460645601781,0.994033204768916,0.46474358974358976,0.9236541953448946,1.0,5/35,4.35%,NEDD4L;STX1A;MCUB;SLC30A1;CALM1
prerank,phosphatase inhibitor activity (GO:0019212),0.43452231172857214,0.9937769676957571,0.4863481228668942,0.920134851383788,1.0,8/20,24.86%,PPP1R9B;PPP1R2;PTN;BOD1;PPME1;SET;ENSA;LMTK2
prerank,ubiquitin protein ligase activity (GO:0061630),-0.2425489475417527,-0.9931119008305749,0.5063291139240507,0.8923313243002492,1.0,50/228,16.51%,RNF220;PDZRN3;RNF152;PELI2;RNF43;SH3RF3;CBLB;AMFR;ASB2;DTX4;DTX3;RNF145;DTX1;RNF217;SH3RF2;TRAF3IP2;MGRN1;PRKN;UBR5;SMURF2;RNF135;LRSAM1;CUL3;UBE4B;KCMF1;TRIM63;RNF10;HUWE1;NHLRC3;WWP2;MYLIP;RNF181;NFX1;PPIL2;RNF149;PRPF19;PELI3;RNF24;FBXO17;SYVN1;RNF121;TRIM9;NSMCE1;TRIP12;RNF144A;DTX2;UBR2;UBR3;MKRN1;RCHY1
prerank,calcium ion binding (GO:0005509),0.2876078355993943,0.9924899927643075,0.48,0.9194689824536427,1.0,47/323,12.62%,SPOCK2;RASGRP3;ESYT2;LTBP4;NOTCH4;RAPGEF2;ADGRL3;TPD52;DYSF;SPARCL1;AGRN;CDH2;PLA2G4B;VIL1;TGM2;CDH20;CALM1;CDH8;CAMKK2;SYT7;ESYT1;RASGRP2;RET;DCHS1;CDH19;SRI;CRNN;CETN2;IQGAP1;ENPP2;NRXN1;SPOCK1;LETM1;DNER;HPGDS;CLGN;LRP2;S100A8;TPM4;PPP3CA;SYT4;CDH10;CDH23;PPP3R1;CALB2;EML1;CPNE6
prerank,histone methyltransferase binding (GO:1990226),0.4749275618967984,0.9923497643200787,0.4725663716814159,0.9156408007145683,1.0,3/11,9.30%,CTNNB1;HSP90AB1;LCORL
prerank,anion:anion antiporter activity (GO:0015301),-0.3952471981625144,-0.9911398600514808,0.47165532879818595,0.8914535162149883,1.0,3/17,8.95%,SLC26A7;SLC26A2;SLC4A2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.46658178470706124,0.9911180822138316,0.4896810506566604,0.9146975498116188,1.0,4/12,18.97%,STAT1;GTF2B;POU2F1;TBPL1
prerank,methylation-dependent protein binding (GO:0140034),-0.2999508708305882,-0.9905226381029186,0.44807121661721067,0.8869166856812705,1.0,12/57,15.30%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2
prerank,nuclear localization sequence binding (GO:0008139),0.4231813725640247,0.9896988871855161,0.46206896551724136,0.9146063873428444,1.0,4/18,19.37%,NFKBIA;RANBP6;NUP153;IPO4
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.43228192643898933,-0.9885922197667206,0.505307855626327,0.8858960625003865,1.0,2/11,18.07%,SLC22A4;SLC25A29
prerank,triglyceride lipase activity (GO:0004806),0.4138844082193821,0.9871703860028481,0.4743362831858407,0.9171523989173561,1.0,2/20,10.76%,LIPE;LIPC
prerank,ephrin receptor binding (GO:0046875),0.4110773126474599,0.9856009838024917,0.4746059544658494,0.9173149420196436,1.0,6/21,7.63%,ANKS1A;LYN;GRB2;FYN;ANKS1B;EFNA1
prerank,potassium ion antiporter activity (GO:0022821),-0.4086747192790545,-0.9846054911657213,0.4978902953586498,0.8913315606568156,1.0,5/15,11.17%,SLC24A3;SLC9A2;SLC9A9;SLC9A1;SLC24A5
prerank,endopeptidase activator activity (GO:0061133),0.4786510608585656,0.9837378214442499,0.4925373134328358,0.9181037079405594,1.0,7/10,27.30%,PSME2;APH1A;VSIR;NLRC4;APH1B;PSME1;ADRM1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4070658618479104,-0.9806574069079378,0.4811529933481153,0.8960887665337605,1.0,1/13,0.81%,PLPP3
prerank,cation:chloride symporter activity (GO:0015377),-0.4448179841746478,-0.9781817627218955,0.49469214437367304,0.897095293996951,1.0,4/10,12.59%,SLC12A2;SLC6A1;SLC12A7;SLC12A4
prerank,protein kinase C binding (GO:0005080),0.3645106580918628,0.9757303953361006,0.4976958525345622,0.9341622427486236,1.0,14/43,14.97%,TIRAP;PRKD2;HDAC9;HDAC7;HINT1;PKN1;CCDC88A;ADCY4;TWF2;CAVIN2;HSPB1;PRKCB;NELL2;HDAC5
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.325696462083903,-0.9751467858574209,0.5170603674540682,0.8993866540862404,1.0,8/34,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UFC1;UBE2B;UBE2Q1
prerank,NAD binding (GO:0051287),-0.348712759789754,-0.9746505484601589,0.470873786407767,0.8946136299040354,1.0,5/26,8.29%,ALDH1A1;CRYL1;ME1;SIRT3;BDH2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4471115717658947,0.9741774185463009,0.49080882352941174,0.9343804160482472,1.0,5/13,13.39%,KCNQ1;PRKAR2B;PRKAR2A;GSK3A;SOX9
prerank,endopeptidase inhibitor activity (GO:0004866),0.3307126485640522,0.9736828145128282,0.5135520684736091,0.9315609953644161,1.0,10/82,9.50%,SPOCK2;APP;SERPINB5;SERPINA9;SERPINA11;BST2;CST7;PZP;SPOCK1;SERPINI1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3453995197471118,-0.9734002651364619,0.4930555555555556,0.8921825298187686,1.0,6/27,6.46%,SLC26A7;SLC26A2;SLC39A14;SLC22A6;SLC5A5;ANO1
prerank,transcription cis-regulatory region binding (GO:0000976),0.27485892165078096,0.9732841754246121,0.5464601769911505,0.9284642798008761,1.0,42/406,9.18%,LEF1;ETS1;FLI1;DACH1;EPAS1;ELK3;ZBTB46;SOX17;MEF2C;SMARCA2;SOX13;MEN1;PRDM2;IRF2;HHEX;FOXF1;RREB1;SOX7;TCF23;BARHL1;KLF1;TAL1;ETV6;TCF7;SNAI2;ACTN4;KLF4;MAX;SOX18;PHOX2A;SOX12;HINFP;JUN;KCNH2;ZFP69;ATF6B;TCF12;PRDM9;CDK5RAP2;ZBTB14;SIM1;HMGA1
prerank,potassium:proton antiporter activity (GO:0015386),0.4645625706131442,0.9719537434711325,0.49209486166007904,0.9278158365107151,1.0,4/10,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.45030842504840807,0.9706689312995801,0.4785992217898833,0.9272553743415157,1.0,5/12,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,N-methyltransferase activity (GO:0008170),-0.3660488683455666,-0.9703552735466165,0.49767441860465117,0.8940082618992834,1.0,6/20,25.40%,HNMT;NNMT;TRMT1L;FDXACB1;DIMT1;RNMT
prerank,transition metal ion binding (GO:0046914),-0.22702310142202348,-0.9698494735921849,0.5943396226415094,0.8893583094708334,1.0,62/397,11.96%,MPPED2;AGMO;GLI2;TIMP2;MOXD1;SMAD3;LARGE1;PAPPA;ENPP1;AOX1;SEC24D;ZFPM2;HDAC4;MMP16;ACER3;CBLB;SEC24A;ANPEP;LOXL3;PAM;ME1;ADCY2;ZMYND8;BAZ1B;KDM7A;MDM4;ENPP3;IKZF4;SOD3;TDP2;UPB1;LACC1;ZEB1;KDM2A;ATP7A;SIRT3;P2RX4;SOD2;CHD3;PRKN;ACE;ENPEP;FBXL19;KDM5B;NPEPPS;EEA1;KDM2B;RBAK;CHD4;CXXC5;PTGR2;ADAM33;SEC23A;B4GALT1;IDE;CRIP1;FAM20C;EPRS1;CXXC4;RXRA;PHF8;ABL1
prerank,metal ion:proton antiporter activity (GO:0051139),0.4438078777993928,0.9685328295831095,0.4875239923224568,0.9286643048303488,1.0,5/13,9.42%,SLC9A5;SLC9A3;LETM1;SLC9A7;SLC9A6
prerank,neurexin family protein binding (GO:0042043),-0.42523673933689154,-0.9680341941498998,0.5191489361702127,0.8883040737859262,1.0,2/10,6.07%,NLGN2;SYTL5
prerank,NAD+ binding (GO:0070403),-0.41834676497928214,-0.9655189837352873,0.5180467091295117,0.8887236379343448,1.0,5/12,23.40%,CRYL1;SIRT3;SIRT2;HADH;SIRT6
prerank,carbohydrate kinase activity (GO:0019200),-0.42498782899586685,-0.9646638631862398,0.5022026431718062,0.8852011184917954,1.0,4/11,16.56%,HK2;GALK1;NAGK;GALK2
prerank,ligand-gated cation channel activity (GO:0099094),0.3250025231481983,0.9645297574292444,0.5155096011816839,0.934566870346491,1.0,18/75,19.84%,MCOLN1;KCNK6;CHRNB1;GRIN3B;KCNH2;GRIA4;KCNN2;KCNN3;P2RX7;GRIN2B;GRIK5;GRIK2;GRIK1;TRPM8;KCNJ3;KCNJ5;KCNJ6;GRIA2
prerank,calcium channel regulator activity (GO:0005246),0.3657180212285987,0.9635996698611383,0.5063694267515924,0.9329659535595658,1.0,7/37,8.93%,MCUB;SLC30A1;PRKG1;CALM1;REM2;SRI;NRXN1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4195270323678289,0.9631709966458759,0.5360443622920518,0.9302191017437775,1.0,6/17,24.32%,AK4;CMPK1;NOL9;AK1;DTYMK;NME2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4637215468521885,0.9616701292788978,0.515426497277677,0.9298640779653888,1.0,4/11,13.64%,PPP1R2;PPP1R11;PPP1R14C;PPP1R8
prerank,SH2 domain binding (GO:0042169),-0.3237990459956084,-0.9600225508291439,0.5526992287917738,0.8913118545925683,1.0,4/31,3.78%,AFAP1;IRS1;SH3PXD2B;DAG1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.4293797010902223,-0.9577107590182685,0.5042372881355932,0.8915717487112335,1.0,6/10,27.39%,NSD2;SETD5;SETD2;NSD1;SMYD2;SETMAR
prerank,pyridoxal phosphate binding (GO:0030170),-0.367490070261825,-0.9568359977875703,0.5167464114832536,0.888279897840031,1.0,10/20,27.79%,PYGB;PYGM;ABAT;OAT;ACCS;THNSL2;PYGL;PNPO;GLDC;SHMT1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.37164617840041664,0.9519331806375213,0.5119047619047619,0.9500047903277052,1.0,9/29,20.82%,GCH1;PTPRJ;DUSP7;DUSP1;DUSP16;DUSP8;TNIP1;ATF7;DUSP6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.46798931960129886,0.9513820232718991,0.5394990366088632,0.9474484314128149,1.0,5/10,24.78%,CDKN2B;KAT2B;INCA1;CDKN1B;CDKN2C
prerank,methylated histone binding (GO:0035064),-0.28486676027119895,-0.948883442554988,0.5527950310559007,0.9032831357665275,1.0,14/62,18.75%,ZMYND8;KDM7A;PYGO1;SGF29;CHD8;CBX5;TDRD3;MBTD1;PHF8;FMR1;MORC3;ZCWPW2;CHD5;PHF2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3705680991661132,-0.9480604619541698,0.49667405764966743,0.8996868333673413,1.0,5/18,11.43%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;AKR1B10
prerank,wide pore channel activity (GO:0022829),0.3901819488669005,0.946416888453358,0.5226890756302521,0.9557240986582197,1.0,2/23,1.84%,GJD3;GJC1
prerank,gap junction channel activity (GO:0005243),0.3935222039581021,0.9461857678911463,0.5320945945945946,0.9523595570000015,1.0,2/22,1.84%,GJD3;GJC1
prerank,transferrin receptor binding (GO:1990459),-0.43545178386055994,-0.9448652164474924,0.5347826086956522,0.9026568928153482,1.0,4/10,15.56%,RGMA;CHUK;CD81;IKBKG
prerank,MAP kinase kinase activity (GO:0004708),-0.38556613130965867,-0.9436818087961225,0.5521064301552107,0.899964892826938,1.0,8/15,22.58%,MAPKAPK3;LRRK2;MAPK14;MAP2K5;MAP2K3;MAP2K1;MAP2K4;MAP3K9
prerank,histone acetyltransferase activity (GO:0004402),-0.32366937557421904,-0.9428693106876609,0.5485564304461942,0.8965280618884334,1.0,14/30,27.92%,ARRB1;KAT6B;HAT1;ATF2;EP300;MCM3AP;BAZ1A;NAA40;TAF9;KAT14;NAA50;CREBBP;KAT8;EPC1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4329312167860904,0.9406900312095225,0.5177304964539007,0.9620181796415428,1.0,3/14,10.49%,MINDY1;ATXN3;MINDY2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4227700625224301,0.9394743163738479,0.5500910746812386,0.9609945713734308,1.0,6/14,18.73%,KCNQ1;KCNH2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,zinc ion binding (GO:0008270),0.2707549890326406,0.9393068498257503,0.6212471131639723,0.9574271488448196,1.0,51/293,13.52%,SHANK3;MYRIP;PDE2A;SORD;GCH1;TNFSF10;KLF7;ARHGEF2;IFIH1;RNF125;BHMT2;PRDM2;SAMHD1;CRIP2;CLIP1;CD4;RPS29;ZDHHC20;KLF4;MSRB2;MSRB3;KAT6A;SHMT2;TIMM13;PDXK;ENPP2;TRIM24;SNRPC;PGGT1B;KDM4A;HPF1;ZMYND11;TIMM10;ZNF205;DUSP12;S100A8;CTCF;GRIN2B;RPS27;GTF2B;PPARG;CYLD;LTA4H;MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,ribosome binding (GO:0043022),-0.2982249622862814,-0.9389751603740946,0.5423728813559322,0.9012931683881011,1.0,15/46,22.70%,CPEB1;CPEB2;MRPS27;EIF3C;FMR1;SRP72;NCLN;IGHMBP2;EIF2A;YTHDF1;SEC61B;C1QBP;SEC61A2;SRP68;CPEB4
prerank,exopeptidase activity (GO:0008238),-0.2927210808193027,-0.9388674907378146,0.5628930817610063,0.8960949343928069,1.0,15/50,21.19%,ANPEP;FAP;NAALAD2;ACE;ENPEP;NPEPPS;DPP4;CTSH;CTSZ;ACE2;ZMPSTE24;CTSA;DPP7;XPNPEP3;GGH
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.380330564942508,0.9383618158255308,0.5339966832504146,0.9559460944216814,1.0,5/25,4.51%,NOS3;CYP2E1;FMO2;FMO4;NOS2
prerank,aspartic-type peptidase activity (GO:0070001),-0.4317506797532431,-0.9378732632639675,0.5485961123110151,0.8931075281481713,1.0,2/10,12.41%,BACE2;PSEN1
prerank,steroid hydroxylase activity (GO:0008395),-0.37414144640895647,-0.9377262653753161,0.5342163355408388,0.8880917420941011,1.0,3/16,5.39%,CYP7B1;CYP27A1;CYP1B1
prerank,Notch binding (GO:0005112),0.3957199213899975,0.9362941462235458,0.559322033898305,0.9572866279255382,1.0,7/22,10.24%,NOTCH4;JAG2;DLL4;DNER;KCTD10;ADAM17;DLK2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3290288068805522,-0.9355046357393575,0.5639097744360902,0.8886250109311193,1.0,4/29,3.53%,SLC13A3;SLC26A7;SLC26A2;SLC1A5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.37638671846072624,0.9352554968488788,0.5350734094616639,0.9559566178032658,1.0,12/28,25.87%,GRID2;CHRNB1;GRIK5;GRIK2;GRIK1;GABRG1;GABRG3;GABRA1;GRIK3;GABRA2;GRID1;GABRG2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.37038239615029916,0.9351294939997865,0.5497553017944535,0.9524183693893007,1.0,6/32,10.86%,KCNQ1;KCNC2;KCNG2;KCNH2;KCNQ3;KCNA4
prerank,chloride channel activity (GO:0005254),0.3266705439581658,0.9334183619548917,0.5674074074074074,0.9525892682259332,1.0,18/59,19.47%,TTYH2;CLCA2;GABRB1;CLCN3;CLIC4;TTYH3;GABRQ;CLCN7;GABRG1;CLCC1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,Hsp70 protein binding (GO:0030544),0.370238801004762,0.9321587871005825,0.535303776683087,0.9518412926646973,1.0,4/31,7.85%,NOD2;CYP2E1;FICD;SACS
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4327461006920514,0.9309213526739897,0.5426944971537002,0.9508988709716071,1.0,4/13,12.15%,PIKFYVE;PIK3C2A;PIP4K2A;PIK3CB
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.42096320737994214,0.9309166470737698,0.5441176470588235,0.9471454238368856,1.0,1/15,3.45%,PLA2G4B
prerank,amino acid:sodium symporter activity (GO:0005283),-0.41510893372983704,-0.9307036412776766,0.5354691075514875,0.895599388889078,1.0,4/11,5.61%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.3892695624878802,-0.9283331192586888,0.5692307692307692,0.8961113554104794,1.0,2/14,17.39%,DHRS3;RDH10
prerank,dynactin binding (GO:0034452),-0.4043251931486782,-0.9282666373722123,0.5570469798657718,0.891027342047824,1.0,5/12,23.65%,SNX6;BICD1;SNX5;BBS4;HTT
prerank,SUMO binding (GO:0032183),-0.3828564647489675,-0.9273937364040933,0.5646551724137931,0.8879893205043642,1.0,6/13,21.97%,TDG;PML;HABP4;USPL1;UBA2;CASP8AP2
prerank,protein heterodimerization activity (GO:0046982),0.2789077772742505,0.9271081505054799,0.616891064871481,0.9522374094299614,1.0,21/178,11.82%,HIP1;EPAS1;PDGFB;BCL2L1;ZHX3;FZD4;MEF2C;RALGAPA1;ABCG1;IKBKB;ATP1A1;MCL1;SRI;YWHAH;IRAK2;SIM1;CYBB;TPM4;MTTP;UBA3;HIF1A
prerank,peptidase activator activity (GO:0016504),0.387309186997672,0.9268576099986447,0.5637583892617449,0.9491815800848149,1.0,5/22,11.81%,CAV1;MAL;PSME2;APH1A;VSIR
prerank,ubiquitin protein ligase binding (GO:0031625),0.27238478063596416,0.9268398991114046,0.6315179606025493,0.9454987518728887,1.0,60/253,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,MAP kinase activity (GO:0004707),-0.3886989530243262,-0.9265794930088066,0.5582959641255605,0.8849635175183355,1.0,1/14,0.68%,MAPK4
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.26939088374209846,0.9219991689335589,0.6503416856492027,0.9530408050681568,1.0,62/268,19.23%,MFHAS1;FZD6;PRR5L;NFKBIA;FZD4;FOXO1;CD40;SMAD7;HSP90AB1;SLC25A5;PRKACB;ATXN3;FBXW7;RFFL;STAT1;RALB;UBE2G1;PRKAR2B;JUN;KCNH2;MAP1LC3B;TUBB;KDM4A;CBS;ACTG1;UBXN1;PRKAR2A;TRIB2;AXIN2;SMAD5;CASP8;UBOX5;HSPA8;HIF1A;MID1;TNK2;HGS;GGN;ARRDC1;UQCRC1;RPL11;BCL10;TPI1;RBX1;DNAJA1;PRDX6;ELOB;RNF8;APC;HERC2;SUMO1;YWHAZ;RALA;BAG6;MAP1LC3A;HSPA9;SLF1;HLTF;UBE2D1;RPL23;TRAF3;USP25
prerank,receptor ligand activity (GO:0048018),0.2708829382723058,0.9188664255050574,0.6511350059737157,0.956824918234205,1.0,27/245,12.66%,KITLG;SEMA3C;SEMA7A;SEMA6A;PDGFB;TGFB2;JAG2;SEMA6B;WNT7A;NPPA;FGF16;SEMA4F;SEMA6D;TGFB1;TGFA;PTN;GREM1;FAM3D;PGF;SEMA4C;METRN;CNTF;PPY;TNFSF11;GDF15;TNFSF12;IL15
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.4441003325797836,0.9184173543530773,0.5846702317290553,0.9541691256177037,1.0,4/12,17.56%,OPN5;GPR52;OPN3;RRH
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.31299934192489376,-0.9179874080320971,0.5714285714285714,0.9007190917516811,1.0,7/31,17.66%,UBE2E2;UBE2R2;UBE2E1;AKTIP;UBE2E3;UBE2B;UBE2Q1
prerank,ATPase activator activity (GO:0001671),-0.3446304435151349,-0.917571053530199,0.570694087403599,0.8965853250053661,1.0,7/20,24.52%,ATP1B3;ATP1B2;TOR1AIP1;DNAJB4;DNAJB2;DNAJC24;AHSA1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.26987276425580675,-0.9161579652872843,0.6341463414634146,0.8950480945161796,1.0,6/70,4.19%,GXYLT2;B3GALT1;LARGE1;EXT1;MGAT4C;OGT
prerank,3'-5' exonuclease activity (GO:0008408),0.33385517688004457,0.9159637998562261,0.5842185128983308,0.9561639492237066,1.0,14/45,21.64%,CNOT6L;NOCT;MRE11;PDE12;PAN2;CNOT6;TRIR;DIS3L;REV3L;EXOSC10;EXOSC9;POLD1;XRN2;RAD1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3725932391835712,-0.915381931277369,0.6216867469879518,0.8917653761156198,1.0,3/16,13.99%,SLC22A4;SLC5A7;SLC22A2
prerank,NF-kappaB binding (GO:0051059),0.378288663277902,0.9144525757555371,0.5746140651801029,0.9560230082050917,1.0,6/24,20.35%,NFKBIA;FOXP3;BCL10;TAF4B;CPNE1;COMMD7
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.25877561353740597,0.9124523581286482,0.7204419889502762,0.9568814766905618,1.0,73/431,15.19%,MFHAS1;ABCC6;INSR;RHOBTB1;MAP4K2;MAP4K3;GCH1;RAB31;STK38;SNRK;ACVRL1;GBP7;GBP4;PRAG1;GBP5;ZAP70;ABCG1;TGM2;SARS2;ABCD4;ARF5;REM2;HSP90AB1;MTPAP;RHOB;PRKACB;RPS6KA5;ATP1A1;ATP1A3;RALB;DNM2;YARS2;RAP1B;FICD;ADSS2;PXK;MARK4;ARL4A;RAB39A;ARHGEF5;TWF2;MAP3K6;PDXK;TUBB;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;RAC1;HRAS;MMAA;RAB4A;TUBD1;ATP5F1A;RND1;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;RHOV;PFKL;TBCK;STK26;DYNC1LI1;TUBB4B;TUBA1A;ARL4D
prerank,mRNA methyltransferase activity (GO:0008174),0.42475590505793176,0.9095236803053511,0.583941605839416,0.9596840317181816,1.0,6/12,23.95%,TRMT10C;CMTR2;TRMT61B;CMTR1;METTL3;PCIF1
prerank,histone acetyltransferase binding (GO:0035035),0.37986072020512657,0.9094833691657809,0.5656742556917689,0.9561383245341494,1.0,5/21,11.82%,EPAS1;STAT1;FOXP3;ZBTB7A;HIF1A
prerank,gamma-tubulin binding (GO:0043015),0.3822073982276937,0.9071919823744836,0.5786713286713286,0.957802101881541,1.0,8/21,17.64%,BRCA2;MARK4;ARHGEF7;CDK5RAP2;PAK1;GIT1;DIXDC1;NDRG1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27393363118401426,0.9050660910366859,0.6581956797966964,0.9589484049305381,1.0,19/173,8.69%,DACH1;ELK3;KLF12;PPARD;TBX3;BCL6B;LRRFIP1;SOX13;ZBTB16;PRDM2;HHEX;ETV6;SNAI2;MAX;INSM1;JUN;ZFP69;FOXP3;ZBTB14
prerank,serine-type peptidase activity (GO:0008236),-0.24747621169907602,-0.9040907470069596,0.6891891891891891,0.9130108145207665,1.0,19/96,18.65%,PCSK5;HTRA3;F3;FAP;MMP2;NAALAD2;KLK2;DPP4;RHBDL3;HTRA1;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,DNA binding (GO:0003677),0.25009814601049174,0.9033815769087451,0.7638453500522466,0.9591594746556036,1.0,91/694,13.76%,LEF1;MECOM;ETS1;FLI1;ERG;EPAS1;KLF12;TRIM16;APP;ZIC3;TBX1;PPARD;TBX3;IMPDH1;LRRFIP1;RYBP;SMARCA2;ARID3B;FOXO1;FOXL2;SOX13;MEN1;YBX1;HMBOX1;KLF2;ZBTB16;PRDM2;IRF2;SAMHD1;HHEX;FOXF1;NTHL1;POGK;MRE11;SNAI2;ZCCHC3;AIM2;NKX2-8;STAT1;MAX;NR1H2;PALB2;IRF5;BRCA2;SOX12;HINFP;KAT6A;JUN;TSHZ2;FOXP3;PRDM9;ELK4;ZBTB14;ARID1A;SIM1;FANCG;DEDD2;HMGA1;ZMYND11;BANF1;MCM10;DNA2;LIN9;OASL;NR5A2;CBFB;TLR8;CTCF;RPS27;GTF2H4;ZBTB7A;HIF1A;MPG;JRK;SOX10;POLG2;TERF1;SLPI;PPARG;GTF3C5;WDR48;ZBTB33;POU2F1;CSRNP3;ORC1;TSNAX;SOX9;FAN1;RPS15;SNAPC1;HMGB2
prerank,mRNA binding (GO:0003729),-0.2183448426520662,-0.8999787226318295,0.8141025641025641,0.9174284079595753,1.0,49/249,17.24%,CELF2;RBMS3;SAMD4A;CPEB1;CPEB2;DDX5;SRRM2;RBMS1;HDLBP;RBPMS2;SRSF5;DCP1A;AUH;CSDC2;SNRNP70;AGO2;RBM47;YBX3;LUC7L3;ZC3H12B;PCF11;XPO5;FUBP1;FXR2;SRRM4;NOVA1;SRSF6;IGF2BP2;SRSF4;ACO1;RNF20;RBM5;LUC7L2;FMR1;HNRNPR;NSRP1;RBFOX1;DDX3X;PCBP4;LARP6;HNRNPA2B1;PABPC4;EIF2A;YTHDF1;TUT1;PABPC4L;FYTTD1;PCBP2;G3BP2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.4036144325781361,-0.8994272114204136,0.5800865800865801,0.9136248121834945,1.0,1/10,0.34%,PRKAG2
prerank,adenyl ribonucleotide binding (GO:0032559),0.25932201043999953,0.8982797830645453,0.720504009163803,0.9671233732507817,1.0,50/291,14.58%,ABCC6;INSR;MAP4K2;PDE2A;RAPGEF2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;MYO6;ABCG1;SARS2;PDE4D;ABCD4;HSP90AB1;MTPAP;PRKACB;RAPGEF4;RPS6KA5;ATP1A1;ATP1A3;YARS2;FICD;PXK;MARK4;PDE4B;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;HMGCR;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,protein phosphatase activator activity (GO:0072542),0.4070868724255595,0.8967216527860186,0.5837837837837838,0.9669307305519595,1.0,4/13,14.63%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,ribonuclease activity (GO:0004540),0.3153818698450213,0.89480961190723,0.6219879518072289,0.9676595405745868,1.0,18/56,22.45%,SAMHD1;PIWIL1;N4BP1;INTS11;RNASEK;RNASE1;CNOT6;RNASE12;TSNAX;PPP1R8;SND1;EXOG;ENDOG;EXOSC10;DICER1;EXOSC9;RNASE6;EXOSC8
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.302281465638465,0.8934509212329352,0.6362297496318114,0.967030388991927,1.0,16/74,12.81%,DGKH;NT5C3A;DGKI;DGKE;CHKA;PKM;PGM2L1;PDXK;PIK3C3;PIK3C2A;HK1;IPMK;DGKZ;PIK3CB;PANK3;NOL9
prerank,phosphatase binding (GO:0019902),-0.24344059882809593,-0.8914777014390459,0.7160493827160493,0.9268395512839368,1.0,26/105,16.52%,EGFR;SMAD3;MAGI2;MAP3K5;IKBKE;ANAPC5;MAST2;DLG1;SH3RF2;DLG4;PDLIM4;AP3B1;MET;SPRED1;MTMR3;PPP1R3C;CRY2;RCAN3;TRPC4AP;HSP90B1;WNK1;PIK3R1;MAPK14;GTF2F1;MVP;NFATC2
prerank,transforming growth factor beta binding (GO:0050431),0.3679214571100483,0.8897072763092729,0.62778730703259,0.9716588127905693,1.0,5/23,5.46%,ENG;LTBP4;ACVRL1;HYAL2;NRROS
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3996977244308416,-0.8874489432369012,0.6318289786223278,0.9259066508253586,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,adenyl nucleotide binding (GO:0030554),-0.3996977244308416,-0.8874489432369012,0.6318289786223278,0.9259066508253586,1.0,3/11,13.66%,SIL1;BAG1;BAG3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.41554377100082607,0.8872514169902742,0.6146616541353384,0.9735568726547458,1.0,3/13,16.55%,DCT;DDT;IDI1
prerank,lysine-acetylated histone binding (GO:0070577),-0.3368879750811379,-0.8845861179051844,0.6069767441860465,0.9222417758053737,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),-0.3368879750811379,-0.8845861179051844,0.6069767441860465,0.9222417758053737,1.0,4/20,9.70%,ZMYND8;PSME4;MLLT3;BRD9
prerank,MAP-kinase scaffold activity (GO:0005078),0.42502740307424547,0.8836624192327217,0.6011029411764706,0.9778547829442942,1.0,3/11,8.39%,SH3RF1;SPAG9;IQGAP1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2987958119892913,0.8798256643840768,0.6575931232091691,0.9827014460765784,1.0,3/75,2.22%,ABCC4;SORD;IMPDH1
prerank,ankyrin binding (GO:0030506),0.3772084868419477,0.8777917250940432,0.5888324873096447,0.9836716224421673,1.0,1/19,0.80%,SPTBN1
prerank,semaphorin receptor activity (GO:0017154),-0.39751830828044565,-0.8772565849094528,0.6152173913043478,0.9334093475324904,1.0,2/11,6.78%,PLXNA2;PLXNB2
prerank,ion gated channel activity (GO:0022839),0.35819461568777566,0.8770811128689309,0.6295652173913043,0.9816567484726394,1.0,3/24,4.96%,TTYH2;TMEM63B;CLCA2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.4013775319101714,0.8769267942631602,0.6113013698630136,0.9784469968593843,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,telomerase RNA binding (GO:0070034),0.36617654442771425,0.8760303106302076,0.6169844020797227,0.9769032921152133,1.0,8/22,21.66%,HNRNPC;DCP2;SNRPB;NHP2;NAF1;EXOSC10;XRN1;PINX1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.27171215342522925,-0.8736027957650293,0.6834319526627219,0.9364058842277583,1.0,10/49,15.04%,ATP1A2;MPPED2;PXYLP1;PTPN22;LHPP;DUSP10;ACP6;ARMT1;PHOSPHO2;ACP2
prerank,phospholipase activity (GO:0004620),0.29978871273920005,0.8711853412171863,0.6685714285714286,0.9832242450405105,1.0,9/67,12.54%,PLCB4;PLA2G4B;PNPLA6;PLD4;GDPD1;ENPP2;LYPLA1;LIPC;PNPLA8
prerank,neuropeptide hormone activity (GO:0005184),0.36875791298601557,0.8692896982543831,0.6327586206896552,0.983625501451604,1.0,3/22,11.07%,NPPA;CALCB;PPY
prerank,general transcription initiation factor binding (GO:0140296),0.3538004081620772,0.8686853516542375,0.649746192893401,0.9814139299075382,1.0,6/25,19.85%,HHEX;TAF1B;YEATS2;GTF2B;THRA;BRF2
prerank,CoA hydrolase activity (GO:0016289),-0.34906177957357676,-0.8675882020205087,0.6599552572706935,0.9446552760503021,1.0,3/16,12.03%,ACOT8;ACOT11;HIBCH
prerank,antiporter activity (GO:0015297),0.36265708015991305,0.867558926022987,0.63,0.9803632148708741,1.0,4/20,12.39%,ATP1A3;CLCN3;SLC35E4;SLC35C1
prerank,double-stranded DNA binding (GO:0003690),0.2437149834360743,0.8657054366597404,0.8474025974025974,0.9809907315448883,1.0,70/531,12.94%,LEF1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;TBX3;BCL6B;MEF2C;FOXL2;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;GATA2;SOX7;CREB1;NTHL1;BARHL1;MRE11;TCF7;IRF9;SNAI2;ZCCHC3;KLF4;AIM2;NKX2-8;STAT1;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;JUN;ATF6B;TERF2;TCF12;KLF6;FOXP3;ELK4;ZBTB14;KLF13;FOXQ1;ZMYND11;ZNF32;CEBPD;ATOH7;ELF2;PKNOX1;SMAD5;NR5A2;LHX5;GTF2H4;ZBTB7A;LHX9;ONECUT1;SOX10;POLG2;TFEB;LHX6;TERF1;ZNF250;PPARG;WDR48
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.30957540107150683,0.8656437849590826,0.6631736526946108,0.977635725732836,1.0,14/49,19.24%,MINDY1;RNF169;UBXN1;OTUD7A;SHARPIN;MINDY2;UBQLN1;EPS15;TNFAIP3;RAD23A;BAG6;TNIP1;BRCC3;OTUD7B
prerank,N-acyltransferase activity (GO:0016410),0.34187809641552624,0.8652794324550345,0.6203389830508474,0.9750632052245073,1.0,4/32,5.58%,CERS4;TGM2;TLCD3B;GLYAT
prerank,calcium activated cation channel activity (GO:0005227),-0.34882457981642734,-0.8650893175609624,0.6378504672897196,0.9455375563817568,1.0,4/17,10.59%,ANO6;KCNMB2;ANO1;TRPM4
prerank,voltage-gated ion channel activity (GO:0005244),-0.3556523415172943,-0.8635440443798673,0.6301075268817204,0.9439393676087676,1.0,2/14,4.66%,ANO6;PKD2
prerank,miRNA binding (GO:0035198),-0.2992653516374741,-0.8623498055222493,0.6766304347826086,0.9413984726442729,1.0,9/30,23.03%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;SPOUT1;RBM10
prerank,serine-type endopeptidase activity (GO:0004252),-0.24664802032368718,-0.8589993898256697,0.8035087719298246,0.94369753890816,1.0,16/80,18.65%,PCSK5;F3;FAP;MMP2;KLK2;DPP4;RHBDL3;CTSH;HTRA2;MASP1;PRSS12;RHBDF1;PARL;MBTPS1;PCSK6;GZMM
prerank,DNA secondary structure binding (GO:0000217),0.33324314430858476,0.8586252154445737,0.637123745819398,0.9858474799215804,1.0,7/31,16.58%,MEF2C;MEN1;HMGA1;RECQL4;HMGB2;MSH2;HMGA2
prerank,Wnt-activated receptor activity (GO:0042813),0.39310528700205083,0.8577305693046191,0.6538461538461539,0.9841896893030726,1.0,4/15,8.59%,FZD6;FZD4;TSPAN12;LRP5
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3871666923403976,0.8574794021292884,0.6462962962962963,0.9812753832951719,1.0,8/14,32.76%,AK4;CMPK1;AK1;DTYMK;NME2;CMPK2;AK8;AK7
prerank,growth factor activity (GO:0008083),0.2889386135538685,0.8554734434833381,0.6876832844574781,0.982005073132092,1.0,7/74,10.58%,PDGFB;JAG2;FGF16;TGFA;PTN;PGF;CNTF
prerank,tau protein binding (GO:0048156),0.32023485385462525,0.8547865060680013,0.656298600311042,0.9800030190976333,1.0,15/40,22.47%,ACTB;HSP90AB1;FYN;MARK4;PIN1;MARK3;GSK3A;BAG2;BIN1;DYRK1A;DCTN1;BRSK2;SNCA;PRKAA1;LGMN
prerank,sodium:proton antiporter activity (GO:0015385),0.4008097334949554,0.8510604565812039,0.6455445544554456,0.9843724740029844,1.0,4/11,9.42%,SLC9A5;SLC9A3;SLC9A7;SLC9A6
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.32956015860880944,-0.8494623590428778,0.6909090909090909,0.9591733795879586,1.0,4/18,10.25%,ANXA2;ANXA1;CNN3;TMOD3
prerank,hexosaminidase activity (GO:0015929),-0.3689124067990214,-0.8477924195193184,0.6652078774617067,0.9573948882547967,1.0,4/12,13.89%,CEMIP;CEMIP2;HEXA;NAGA
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3391320377185717,0.8461283497257525,0.6513911620294599,0.991375247166413,1.0,5/29,10.98%,ACER2;HYAL2;ACER1;PARG;MGAM
prerank,leucine zipper domain binding (GO:0043522),-0.3794324637165594,-0.8453152699867452,0.6703056768558951,0.9574227223369295,1.0,1/10,0.50%,PAWR
prerank,retinoic acid receptor binding (GO:0042974),0.3656273973993664,0.845029946611534,0.6642984014209592,0.9903471489937974,1.0,4/17,12.84%,ACTN4;TACC1;HMGA1;PPARG
prerank,single-stranded DNA binding (GO:0003697),-0.23628769845549444,-0.8442187500919384,0.8047945205479452,0.9548222609454102,1.0,35/93,32.97%,SSBP2;TOP1;RBMS1;FBH1;TDP2;RAD51B;FUBP1;RBBP8;REXO4;SMC6;CRY2;NUCKS1;IGHMBP2;ERCC1;PCBP2;DMC1;CDC45;TDP1;MCM3;MCM4;MCM5;MCM9;HMGB1;NUP35;HMCES;RAD51AP1;SETMAR;DHX36;SPRTN;NEIL3;MEIOB;PCBP1;RAD52;POU4F1;MCM8
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.397140204432424,0.8437745648926496,0.6394316163410302,0.9895313586871913,1.0,6/12,21.31%,CDK19;BRD4;CCNK;MAPK1;CDK6;CDK4
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30121695689227423,-0.8430269373037523,0.7182741116751269,0.9524593851661848,1.0,12/28,22.58%,PRKAA2;PRKACA;MAPKAPK3;LRRK2;MAPK14;MAP2K5;RPS6KB1;MAP2K3;TTK;MAP2K1;MAP2K4;MAP3K9
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2332824740201331,0.8393184214935117,0.8732840549102429,0.9950165136153627,1.0,77/597,13.39%,LEF1;ETS1;FLI1;ERG;ELK3;KLF12;ZIC3;TBX1;PPARD;SOX17;TBX3;BCL6B;MEF2C;SMARCA2;FOXL2;SOX13;BACH2;MEN1;YBX1;HMBOX1;KLF2;IRF2;HHEX;GATA2;SOX7;CREB1;BARHL1;KLF1;TAL1;TCF7;IRF9;SNAI2;KLF4;NKX2-8;MAX;POU3F4;IRF5;SOX18;PHOX2A;NFIC;SOX12;HINFP;JUN;KCNH2;ATF6B;TCF12;KLF6;FOXP3;PRDM9;ELK4;CDK5RAP2;ZBTB14;KLF13;FOXQ1;ZNF32;CEBPD;MCM10;ATOH7;ELF2;PKNOX1;SMAD5;CDC6;NR5A2;LHX5;CTCF;ZBTB7A;LHX9;ONECUT1;SOX10;TFEB;LHX6;SOX11;ZNF250;PPARG;ZBTB33;ORC1;SOX9
prerank,peptide hormone receptor binding (GO:0051428),-0.36867560762796253,-0.8378219357475534,0.6595289079229122,0.958505101470098,1.0,7/11,49.80%,PTHLH;VIP;GNRH1;UCN2;GPHB5;PSMC5;GHRH
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3622954978495554,0.8374929811938372,0.6555944055944056,0.9952576771525414,1.0,6/18,12.34%,ENG;TGFB2;SMAD7;TGFB1;FERMT2;TGFBR2
prerank,hydro-lyase activity (GO:0016836),-0.2674617599642456,-0.8368713686893371,0.7255434782608695,0.9555103235109305,1.0,20/41,26.71%,GMDS;HACD4;AUH;ECHDC2;HACD1;ACO1;ECHDC1;PCBD2;ECHDC3;EHHADH;CYP2S1;ENO2;ECI1;ENO3;HADHA;ALAD;L3HYPDH;ECHS1;UROS;ACO2
prerank,acetyltransferase activity (GO:0016407),-0.2885154636482855,-0.8349251039064696,0.7282051282051282,0.9543384036060768,1.0,13/31,26.41%,KAT6B;SAT1;ELP3;NAA80;SPHK1;PAFAH2;EP300;SAT2;NAT8L;DBT;NAA50;CREBBP;KAT8
prerank,adrenergic receptor binding (GO:0031690),0.3756742069943827,0.8331212248346963,0.6506024096385542,1.0,1.0,2/16,4.53%,RAPGEF2;PDE4D
prerank,exoribonuclease activity (GO:0004532),0.38414441307574604,0.8324765581312034,0.6551059730250481,0.9985574582269684,1.0,7/12,32.97%,CNOT6;EXOSC10;EXOSC9;EXOSC8;ZC3H12A;CNOT7;EXOSC3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.25218334337656767,0.8323834439244814,0.8055555555555556,0.9954297758652548,1.0,21/181,8.90%,LMO2;PPARD;NFKBIA;TBX3;NCOA1;ZFPM1;ACTB;CTNNB1;TCF23;CREB1;TAL1;ACTN4;KLF4;STAT1;GTF2I;BUD31;NCOA2;TACC1;JUN;FOXP3;ARID1A
prerank,transaminase activity (GO:0008483),-0.3679696877073937,-0.8295632860820717,0.6724511930585684,0.9600381294846513,1.0,3/11,11.70%,ABAT;OAT;GOT1
prerank,chloride channel regulator activity (GO:0017081),0.37928051119747974,0.8269003453011889,0.6721915285451197,1.0,1.0,6/14,23.39%,STX1A;SGK1;SGK3;WNK2;VAMP8;STX8
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3309294928765119,0.8251274101840164,0.7004830917874396,1.0,1.0,4/28,11.45%,DAB2IP;STAT1;PIDD1;TNFSF11
prerank,potassium channel regulator activity (GO:0015459),-0.2565772263380883,-0.8244077273593529,0.7827380952380952,0.9651076832998182,1.0,6/49,6.15%,WNK4;KCNIP3;KCNMB2;ABCC9;DLG1;FLNA
prerank,G protein-coupled receptor binding (GO:0001664),0.25891718556852616,0.8232018569919499,0.7963683527885862,1.0,1.0,18/132,11.07%,CXCL12;REEP1;S1PR1;GNAI2;GNAQ;WNT7A;ZNRF3;HOMER2;GNA12;NPPA;INSL3;HOMER1;ARHGEF12;RTP4;UTS2B;CALCB;HSPA8;PPY
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.27624825694836136,-0.8224945467205647,0.7289972899728997,0.9640912294546357,1.0,15/34,28.73%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;KMT5B;EZH2;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;TTLL12;ANTKMT;METTL21C
prerank,filamin binding (GO:0031005),0.39845081443579744,0.8224373598525008,0.6585820895522388,1.0,1.0,2/11,4.13%,NEBL;RFLNB
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3256127365495339,-0.8183176134330847,0.7270642201834863,0.9670226951082052,1.0,2/15,13.00%,CCR9;CMKLR1
prerank,retinoid X receptor binding (GO:0046965),0.38684216256755893,0.8157092601556795,0.6791044776119403,1.0,1.0,3/11,12.84%,TACC1;HMGA1;PPARG
prerank,bHLH transcription factor binding (GO:0043425),-0.31647523240225933,-0.815161185436313,0.706601466992665,0.9679734367174312,1.0,2/19,1.40%,FHL2;SMAD3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.306464218182499,0.8126757953542268,0.7265745007680492,1.0,1.0,5/38,9.08%,SHANK3;CARD10;SORBS1;SPAG9;DEDD2
prerank,deubiquitinase activity (GO:0101005),0.26616350453186655,0.8120182988244908,0.7745504840940526,1.0,1.0,23/88,20.14%,USP53;MINDY1;ATXN3;EIF3F;OTUD7A;MYSM1;MINDY2;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,protein serine/threonine kinase activity (GO:0004674),0.23301106006755873,0.8104371666346262,0.8923766816143498,1.0,1.0,71/334,18.24%,PRKCH;BMPR2;MAP4K2;MAP4K3;STK38;PKN3;KALRN;SNRK;RPS6KA1;ACVRL1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;MAP3K8;PRKD3;IKBKB;PIKFYVE;MAST4;PKN1;LIMK2;PAK5;MAPK3;RPS6KA5;PKN2;MARK4;MARK3;MAP3K6;IRAK2;PAK1;EIF2AK4;STK33;BRD4;STK32C;SLK;PRKCB;GSK3A;SYK;CCNK;PDIK1L;MAP4K4;TGFBR2;RIOK1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;CAMK2B;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2;MAPK1;CPNE3;ACVR1;SIK2;TTN;MAP3K11;PRKCG;PRKCE;TBK1;PAK2;WNK2;CDK11B
prerank,protein tyrosine kinase activator activity (GO:0030296),0.34248310236774254,0.8076783544784737,0.7082601054481547,1.0,1.0,8/19,29.08%,AFAP1L2;GREM1;GAS6;PAK2;NRG3;EGF;GRM5;DGKQ
prerank,peptide N-acetyltransferase activity (GO:0034212),0.39506707239572303,0.8073953328940903,0.6929982046678635,1.0,1.0,3/10,13.40%,NAA60;NAA16;NAA11
prerank,sodium channel activity (GO:0005272),-0.2663341389500549,-0.8043645768011093,0.7848101265822784,0.9823884622539926,1.0,3/37,4.90%,SCN7A;PKD2;CACNA1G
prerank,chemokine receptor activity (GO:0004950),0.3380497148527476,0.8039007254572829,0.7400346620450606,1.0,1.0,5/24,17.12%,CCR7;GPR17;CXCR2;GPR75;CCR2
prerank,solute:proton symporter activity (GO:0015295),0.3614327037046114,0.8030415188029854,0.7152899824253075,1.0,1.0,1/16,1.24%,SLC39A8
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.34913462048413535,-0.8029835750205434,0.717391304347826,0.9801836212984791,1.0,2/12,7.30%,CYFIP2;AGO2
prerank,histone deacetylase activity (GO:0004407),-0.3110030165197875,-0.8021587637099181,0.7326086956521739,0.9769332257921826,1.0,3/19,6.86%,HDAC4;MIER3;SIRT3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.28558952632372875,-0.8005411373478679,0.7555555555555555,0.9748514176068992,1.0,6/26,15.39%,AEBP1;CPXM1;CPXM2;AGBL1;PEPD;ACE2
prerank,voltage-gated potassium channel activity (GO:0005249),0.2694637314905748,0.7967587771383683,0.8176555716353111,1.0,1.0,20/80,19.44%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNN3;KCNQ3;KCNV1;KCNA4;KCNH7;HCN2;KCNF1;KCNJ3;KCNJ5;KCNJ6;KCNA5;KCNIP2;KCNC1
prerank,GABA-A receptor activity (GO:0004890),0.3529010083926244,0.796551996084395,0.7018739352640545,1.0,1.0,8/18,25.87%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36362254345834877,-0.7960989324894233,0.7194860813704497,0.9777233592058574,1.0,1/10,6.61%,LACC1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3579319634357431,-0.7950226809085056,0.7247706422018348,0.974807818582113,1.0,7/10,29.25%,HAT1;ATF2;EP300;NAA40;NAA50;KAT8;MSL3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.25670352152714826,-0.7944261739299006,0.8005952380952381,0.9712609684314272,1.0,8/40,13.80%,DNMT3A;PCMT1;HNMT;NNMT;THUMPD3;ARMT1;COMT;PRMT8
prerank,ATP binding (GO:0005524),0.23156194168096914,0.7942979623209504,0.9049826187717266,1.0,1.0,43/266,14.58%,ABCC6;INSR;MAP4K2;MAP4K3;STK38;SNRK;ACVRL1;PRAG1;ZAP70;ABCG1;SARS2;ABCD4;HSP90AB1;MTPAP;PRKACB;RPS6KA5;ATP1A1;ATP1A3;YARS2;FICD;PXK;MARK4;TWF2;MAP3K6;PDXK;P2RX7;TAP2;MYO1F;HSPA8;EIF2B2;ABCD1;ATP5F1A;MAP4K4;PANK3;PNPLA8;NOL9;STK3;MINK1;HACL1;MOV10L1;PFKL;TBCK;STK26
prerank,kinase activator activity (GO:0019209),-0.27740608686626084,-0.7925996770652415,0.7938144329896907,0.9697052858246514,1.0,7/30,15.71%,PRKAG2;GPRC5C;STK11;STRADA;WNK1;WNT11;GPRC5A
prerank,phosphatase activity (GO:0016791),0.2702746951654417,0.7903631518622766,0.7792022792022792,1.0,1.0,17/73,17.46%,PTPRJ;PTPMT1;DUSP23;DUSP3;PLPP6;NOCT;OCRL;PPP1CB;ACP4;DUSP12;DUSP16;ENOPH1;LPIN3;DUSP8;PLPPR4;PLPP2;MINPP1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.34219132700730787,-0.7895237575550179,0.7208791208791209,0.9704785305385695,1.0,6/11,23.23%,CASP12;CASP3;CASP6;CASP4;PYCARD;CASP9
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3542719628928172,0.7868671302833444,0.7306273062730627,1.0,1.0,1/15,1.24%,SLC39A8
prerank,chemoattractant activity (GO:0042056),0.3215882192424786,0.7861988107846968,0.7601351351351351,1.0,1.0,1/26,0.84%,PDGFB
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.26786671078006546,0.7851061305888,0.7902511078286558,1.0,1.0,14/69,16.94%,CERS4;ZDHHC14;ZDHHC9;GLYAT;ZDHHC20;KAT6A;AWAT2;ZDHHC18;LPCAT3;GTF2B;NAA16;MOGAT2;ZDHHC21;DGAT1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.38298458826500437,0.7846913818691619,0.7310606060606061,1.0,1.0,1/10,2.13%,CD200
prerank,DNA-binding transcription factor binding (GO:0140297),0.23661509035517136,0.7846284158694745,0.8787515006002401,1.0,1.0,38/189,17.74%,LMO2;PPARD;TBX3;MEF2C;ZFPM1;HDAC9;HDAC7;PTMA;HHEX;CTNNB1;TCF23;CREB1;TAL1;CRTC1;KLF4;STAT1;GTF2I;TLE4;JUN;TCF12;HSPB1;ZBTB7A;TLE1;EIF4E;PPARG;HIPK2;ZBTB17;BBS10;SP1;CTBP1;HDAC5;RBL1;HCFC1;MEF2D;YWHAZ;LYAR;SIN3A;USF1
prerank,death receptor binding (GO:0005123),0.35247186389593094,0.7817751143726154,0.7460869565217392,1.0,1.0,2/15,8.31%,DAB2IP;PIDD1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.340155932564341,-0.781561216345412,0.7326315789473684,0.9782890633526697,1.0,2/11,11.43%,AKR1B1;AKR1B10
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.33284456637219934,-0.7800864425396384,0.729957805907173,0.9760987652030892,1.0,3/12,15.69%,BACE2;PSEN1;HM13
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.2864388538879771,-0.7741475821373982,0.7718446601941747,0.9758860880236334,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.2864388538879771,-0.7741475821373982,0.7718446601941747,0.9758860880236334,1.0,9/21,25.48%,CDK8;CDK14;CDK7;CDKL1;CDKL3;CDK5;CDK12;CDK10;CDK9
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.25435068471800243,-0.7730828023973539,0.8347578347578347,0.973162333175872,1.0,6/34,14.30%,FAM20A;CCNT2;IGF2;CAB39L;STRADA;DDX3X
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.34061937482603893,-0.7700221093085505,0.7570498915401301,0.9734755370582412,1.0,3/10,8.93%,FAP;NAALAD2;DPP4
prerank,RNA binding (GO:0003723),0.20889584332666752,0.7687151257677247,0.9939393939393939,1.0,1.0,313/1321,22.07%,TFRC;SORBS2;RBM20;SPTBN1;SYNE1;MACF1;NANOS3;NOVA2;QKI;FASN;PRPF38B;AGFG1;TRIM25;FLNB;LRRFIP1;MAP4;IFIH1;YBX1;NPM3;MSI2;TMSB4X;ADAR;SAMHD1;SARS2;SARS1;GRB2;SELENOH;NANOS2;NOCT;MRPL12;PIWIL1;HSP90AB1;RPL38;SLC25A5;MTPAP;EFTUD2;EIF4H;TLR3;NOL4;MRPL13;RPL13;NANOS1;PPIA;ACTN4;GPATCH1;PIN4;ZCCHC3;MRPL10;EDC3;RPL36A;PTBP3;MAK16;RPL3;ABT1;PKN2;STXBP1;ZNFX1;RNPS1;ACTN1;N4BP1;YARS2;BST2;RPL27;NPM2;RPSA;TLR7;MRPL14;JUN;SRP14;SNU13;TIAL1;PKM;NOP16;TDRD7;TWF2;EIF3E;RPS7;CSTF2;DHX37;RPL9;PDAP1;MSN;SNRPF;RPL18;SLC3A2;HNRNPC;SNRPC;GTPBP1;CCT3;PDCD11;RBM19;SCG3;EIF2AK4;LRRC47;MAGOHB;DNA2;RPL13A;EIF3D;OASL;EIF5A;ZCRB1;GFM1;HSPA8;HELZ2;HSPB1;TASOR;TLR8;RPS11;LARP1B;WDR36;RPL8;DCP2;MPHOSPH10;RBPMS;NCBP2;RPS27;PWP2;RPL19;GPKOW;NOL10;TRMT10C;RBM45;R3HDM1;UTP3;MRPL54;ATP5F1A;NELFCD;DXO;RPS9;MRPL28;ZFP36L1;MRPL20;RPP38;ASCC3;EIF4E;SLPI;ADAD1;RO60;EDF1;SNRPB;DCP1B;ZC3H11A;DHX32;PUM3;KMT2C;CCDC137;RBM42;TSNAX;RPL11;LTA4H;FSCN1;EIF3B;EIF3G;PPP1R8;ZC3H7A;RPL22L1;RPS15;HMGB2;PSTK;SRBD1;RPL37;METAP2;FAM98A;RPS28;STIP1;MOV10L1;SERBP1;RFTN1;ESF1;EIF3L;G3BP1;DYNC1LI1;RPS10;ELAVL1;UTP11;LBR;COA6;PNO1;TNS1;YTHDC2;ZBED4;TUBB4B;RTRAF;DDX55;FBRSL1;RALYL;IREB2;RCC2;NOC4L;FRG1;SND1;TSN;UBTF;EIF1B;NOL7;MRPL40;RPS25;AQR;MCRS1;MRPL44;ZC3HAV1;RPL37A;CS;YLPM1;MRPS9;MRPL9;PRPF40A;ZC3H13;ISG20L2;CPNE3;FAU;UBAP2;RPP21;DDX18;NHP2;RBFOX3;UNC50;SUMO1;EIF4A1;ALKBH8;YWHAZ;CSTB;NTPCR;NOL8;MYH10;ISY1;LYAR;SAMSN1;NUDT1;HSPA9;RPL15;RANGAP1;NAF1;HLTF;DEK;SF3A2;HSPE1;MSI1;CDK11B;DDX11;LSM4;RBM38;RRP12;SNRPD2;EXOSC10;S100A16;MRPL16;MRPL23;RPL17;RPL23;XRN1;RPL34;CMSS1;OTUD4;DICER1;PUF60;SUCLG1;MRPL39;HNRNPLL;CDC5L;CCDC9B;RBM8A;RBMS2;RPS18;RTCB;GTF2E2;NUDT16;WDR75;DAZL;ZFP36L2;MECP2;TRMT2A;EXOSC9;NOC2L;CAPRIN1;APEH;THUMPD1;JMJD6;HNRNPM;ASS1;ELAVL2;XRN2;MRPL21;GCN1;NSUN6;GRWD1;NVL;XPOT;RBM15;RPL21;RDX;RADX;LRPPRC;HSD17B10;RPS4X;DDX54;ARL6IP4;EIF3H;RPP30;METTL3;RPL18A;NCBP1;HMGN5;PINX1;TXN;RPS21;NUP42;ZNF638;SUB1;RACK1;PEF1;DUSP11;RBM27
prerank,Tat protein binding (GO:0030957),-0.35136148728543826,-0.7681888700495387,0.745958429561201,0.9716703252816943,1.0,2/10,8.30%,MDFIC;SMARCB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.34240549040077517,0.7645278724293101,0.7530864197530864,1.0,1.0,3/16,10.50%,NTHL1;CD38;SMUG1
prerank,C-C chemokine receptor activity (GO:0016493),0.3232398916006572,0.7631416477991586,0.754325259515571,1.0,1.0,4/21,17.12%,CCR7;CXCR2;GPR75;CCR2
prerank,phosphatase activator activity (GO:0019211),0.348796560153245,0.7631292075594036,0.7425925925925926,1.0,1.0,4/14,14.63%,CALM1;PPP2R5A;PHACTR4;B3GAT3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2603780313795698,0.7627179994367992,0.8451519536903039,1.0,1.0,14/73,16.82%,HCRTR1;APLNR;CALCRL;OXTR;SORCS1;NLRP6;HCRTR2;NPR1;CYSLTR1;ADCYAP1R1;RXFP3;RXFP2;OPRD1;GLP1R
prerank,potassium channel activity (GO:0005267),0.25018940264134204,0.7616551666950706,0.8667582417582418,1.0,1.0,16/89,14.51%,KCNH8;KCNQ1;KCNC2;KCNK6;KCNG2;KCNH2;KCNN2;KCNQ3;KCNV1;KCNA4;KCNH7;GRIK5;GRIK2;HCN2;GRIK1;KCNF1
prerank,endopeptidase regulator activity (GO:0061135),-0.24326252258966846,-0.7578794590977129,0.8567335243553008,0.982830024370398,1.0,5/40,11.00%,TFPI;ITIH2;SERPIND1;RENBP;PSME3
prerank,syntaxin binding (GO:0019905),0.26321341579262747,0.7577634195817587,0.8388059701492537,1.0,1.0,10/61,15.70%,CACNA1A;UNC13B;SYPL1;STXBP1;RAB11A;SYNPR;SNAP29;CPLX1;SYPL2;SCFD2
prerank,sequence-specific mRNA binding (GO:1990825),-0.3376679531615159,-0.7541724726034811,0.77079107505071,0.9839707289488921,1.0,3/10,22.46%,FMR1;LARP6;RBM24
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.35433902140947965,0.7528284770134065,0.7319223985890653,1.0,1.0,1/12,2.77%,NOD1
prerank,voltage-gated cation channel activity (GO:0022843),0.24476169091833727,0.7509788929372737,0.8795013850415513,1.0,1.0,14/97,12.88%,KCNH8;CACNA1A;KCNQ1;KCNC2;CACHD1;KCNG2;GRIN3B;KCNH2;KCNQ3;KCNV1;KCNA4;GRIN2B;KCNH7;HCN2
prerank,ADP binding (GO:0043531),-0.27525922631849126,-0.7494902405103867,0.8096385542168675,0.9861227617704967,1.0,2/25,4.11%,PRKAG2;ME1
prerank,3'-5' DNA helicase activity (GO:0043138),0.3305312627781397,0.7462392413111745,0.7768014059753954,1.0,1.0,3/16,12.65%,NAV2;RECQL4;ASCC3
prerank,CCR chemokine receptor binding (GO:0048020),0.30183381370859447,0.7458895564077357,0.7920792079207921,1.0,1.0,6/28,24.66%,NES;CCL1;CCR2;CCL25;CNIH4;NARS1
prerank,histone methyltransferase activity (GO:0042054),-0.2530954156171927,-0.74458143367428,0.8473282442748091,0.9884229596789652,1.0,10/32,20.69%,EHMT2;SMYD3;SETD7;PRMT5;PRMT8;KMT5B;EED;EZH2;SETD2;KMT5A
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.27239979047357227,0.742465688739618,0.833063209076175,1.0,1.0,13/42,24.78%,CCNY;CDKN2B;CCNI;CCND3;CCNK;CCNL2;CCNT1;KAT2B;CCNQ;CCNJL;INCA1;CDKN1B;CDKN2C
prerank,chemokine activity (GO:0008009),0.2933096862291325,0.7421667274798278,0.7909238249594813,1.0,1.0,1/31,1.41%,CXCL12
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.30491203099549624,-0.7408363788080488,0.7958715596330275,0.988879473554008,1.0,3/13,11.20%,THUMPD3;TRMT10B;TRMT1L
prerank,inward rectifier potassium channel activity (GO:0005242),0.30522467633168265,0.7390456671503625,0.7981818181818182,1.0,1.0,7/24,18.38%,KCNK6;KCNH2;KCNN2;KCNN3;KCNJ3;KCNJ5;KCNJ6
prerank,glycine binding (GO:0016594),0.36136671081699206,0.7381886850332096,0.7853211009174312,1.0,1.0,6/11,28.95%,GRIN3B;GRIN2B;GLRA2;GRIN1;GLRA1;GRIN3A
prerank,nucleosomal DNA binding (GO:0031492),-0.2750595600866345,-0.7368612203936772,0.8325358851674641,0.9896679695911114,1.0,6/21,18.14%,SMARCC2;SMARCB1;CHD4;MBD2;SMARCC1;RBBP4
prerank,5'-nucleotidase activity (GO:0008253),0.34040543715890126,0.7359868414329537,0.7859848484848485,1.0,1.0,2/13,5.23%,NT5C3A;NT5C2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.30496996256262926,0.7344307486805969,0.8121739130434783,1.0,1.0,4/21,13.66%,WASF2;KCNQ1;AKAP9;AKAP6
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3238479445660566,-0.7342517917335993,0.7833333333333333,0.9889419889853369,1.0,2/11,14.36%,SLC5A3;SLC2A10
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.35521917113879026,0.7342045680906262,0.7663043478260869,1.0,1.0,7/12,25.87%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.31911162009655203,-0.7334540502526982,0.831140350877193,0.9856140231787985,1.0,1/12,1.07%,B3GALT1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3294613283083899,0.7329547348237039,0.7837837837837838,1.0,1.0,6/16,19.21%,INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,ubiquitin binding (GO:0043130),-0.2084926364140719,-0.7322264919004617,0.9415584415584416,0.9828662633568486,1.0,23/73,24.37%,SMAD3;TSG101;PRKN;RNF31;OTULINL;AUP1;SIRT2;IKBKG;DNAJB2;USPL1;MVB12A;TOP2A;NBR1;USP16;USP13;ASCC2;RAE1;OTUB1;NEDD4;TOM1L1;UBAP1L;UBXN2A;UCHL3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.35342701835842316,0.7261083001123246,0.7709090909090909,1.0,1.0,5/11,29.30%,TERF2;TERF1;RPA1;NABP2;HNRNPA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.31626297539271686,-0.7254631120522893,0.8052516411378556,0.9871576752839623,1.0,5/12,16.82%,AOX1;SDHB;FXN;CISD2;FDX1
prerank,chemokine receptor binding (GO:0042379),0.2795790240262224,0.7251614445130399,0.8283464566929134,1.0,1.0,1/35,1.41%,CXCL12
prerank,nucleotidase activity (GO:0008252),0.32456162133015054,0.7214273000315686,0.800376647834275,1.0,1.0,2/15,5.23%,NT5C3A;NT5C2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.31186684539098375,0.7188874622344217,0.800711743772242,1.0,1.0,1/16,5.35%,PIR
prerank,ribosomal small subunit binding (GO:0043024),0.3139492369496187,0.7150146104847491,0.8137082601054482,1.0,1.0,10/17,28.37%,EIF4H;MTIF3;EIF1B;EIF4B;ABCE1;PIM1;ERAL1;PTCD3;EIF1;DHX29
prerank,nuclease activity (GO:0004518),0.25888531907020396,0.7130409634831019,0.8728414442700158,1.0,1.0,13/52,18.00%,SAMHD1;NTHL1;MRE11;N4BP1;DFFB;DNA2;PDE12;RNASE1;RNASE12;SND1;ISG20L2;EXOG;ENDOG
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3403593943200301,0.7120655469009876,0.7937956204379562,1.0,1.0,5/12,24.93%,STAT1;TNFSF11;TRAF3;TRAF6;TRAF1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.19933828963107353,-0.7111527921118457,0.9691780821917808,1.0,1.0,30/78,29.20%,USP11;USP24;CTSL;USP40;CASP12;USP2;CTSH;USP42;USP9X;CTSZ;CAPN1;CASP3;SFRP1;CASP6;CASP4;USP16;USP13;PYCARD;USP15;CASP9;CAPN15;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;GPAA1;USP33
prerank,cysteine-type peptidase activity (GO:0008234),-0.20697556522855567,-0.7096232317437485,0.9727891156462585,0.9974750646794148,1.0,30/73,29.20%,USP11;USP24;CTSL;USP40;USP2;ATG4A;OTULINL;CTSH;USP42;USP9X;CTSZ;CASP3;USP50;SFRP1;CASP6;CASP4;USP16;USP13;OTULIN;GGH;USP15;CASP9;USP10;USP37;USP36;USP20;USP47;USP9Y;USP1;USP33
prerank,chloride channel inhibitor activity (GO:0019869),0.34266355313494223,0.707897158629201,0.7870370370370371,1.0,1.0,1/10,2.69%,STX1A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.3021492958649273,-0.7068817397166519,0.8676122931442081,0.9961924915253673,1.0,3/13,15.25%,GABRA3;GLRB;GABRE
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3413881040905944,0.7068722543373679,0.8122743682310469,1.0,1.0,3/11,13.40%,NAA60;NAA16;NAA11
prerank,UDP-galactosyltransferase activity (GO:0035250),0.33610019926499074,0.7061531583155942,0.7905660377358491,1.0,1.0,3/10,13.25%,B4GALT5;B3GALT4;B3GALT2
prerank,thioesterase binding (GO:0031996),0.3405217210003719,0.7028224958644786,0.8249097472924187,1.0,1.0,6/11,29.34%,RAC1;TRAF3;TRAF6;TRAF1;CDC42;TRAF2
prerank,DNA replication origin binding (GO:0003688),0.28717982570338446,0.702110807157128,0.8543046357615894,1.0,1.0,6/23,21.01%,MCM10;CDC6;ORC1;DDX11;GRWD1;POLA1
prerank,regulatory RNA binding (GO:0061980),-0.22447000850259025,-0.6991625840215424,0.938337801608579,1.0,1.0,11/38,23.03%,TUT4;ZC3H7B;AGO2;FMR1;HNRNPA2B1;MATR3;ZC3H10;TARBP2;PIWIL2;SPOUT1;RBM10
prerank,ubiquitin-dependent protein binding (GO:0140036),0.34147621461626965,0.697545505540678,0.7973231357552581,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24950075611876651,0.6971935765916748,0.8980509745127436,1.0,1.0,5/54,5.12%,ACER2;HDAC9;TGM2;HINT1;ACER1
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.27579235773236593,-0.6967266259841828,0.8618421052631579,0.9988561860838304,1.0,12/17,46.74%,ACOT8;ACOT11;PLA2G6;THEM4;ACOT1;ACOT13;ACOT12;ACOT2;ACAA2;BAAT;ACOT4;ACOT7
prerank,tau-protein kinase activity (GO:0050321),-0.2677042242908936,-0.6960686175037072,0.8775,0.9952685385662806,1.0,2/20,5.88%,ROCK2;MARK1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.24652773490550445,-0.6955783672154141,0.9129287598944591,0.9915986651018345,1.0,8/27,26.27%,POLR2A;POLR3K;POLR1C;PRIMPOL;POLR2L;POLR1D;POLR3A;POLR2I
prerank,GABA receptor activity (GO:0016917),0.2991804563929325,0.6951014773399892,0.8406779661016949,1.0,1.0,9/21,25.87%,GABRB1;GABRQ;GABRG1;GABRG3;GABRA1;GABRB2;GABBR2;GABRA2;GABRG2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.29239537194255455,0.6943286570987256,0.823327615780446,1.0,1.0,2/22,3.63%,ATP2C1;ATP6V0A1
prerank,ligand-gated anion channel activity (GO:0099095),0.3145683063838711,0.6932037821146056,0.846815834767642,1.0,1.0,9/17,25.87%,GABRB1;GABRG1;GABRG3;GABRA1;GABRB2;GLRA2;GABRA2;GLRA1;GABRG2
prerank,receptor antagonist activity (GO:0048019),-0.2785478993709029,-0.6911731696823082,0.8594847775175644,0.9920709399405523,1.0,1/17,1.64%,DKK3
prerank,DNA polymerase binding (GO:0070182),0.30008346579614026,0.6899235421081291,0.8290155440414507,1.0,1.0,7/18,25.09%,HSP90AB1;ACD;POLG2;LONP1;PTGES3;NABP2;SMARCA4
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2460150031697127,-0.6896709930004463,0.8951406649616368,0.9893777476859152,1.0,8/27,26.27%,POLR2A;TENT2;POLR3K;POLR1C;POLR2L;POLR1D;POLR3A;POLR2I
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33054384350806104,0.6867866667881696,0.8330206378986866,1.0,1.0,1/11,7.08%,CHRNB1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2733574284819484,0.6867556323056173,0.8922056384742952,1.0,1.0,13/29,25.85%,PKIG;CDKN2B;PRKAR2B;PRKAR2A;HSPB1;RPTOR;KAT2B;INCA1;CDKN1B;SFN;CDKN2C;PRKAR1A;INKA2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3072304274432215,-0.6864442574648723,0.8562091503267973,0.9881906877187921,1.0,5/10,23.23%,CASP12;CASP3;CASP6;CASP4;CASP9
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.33551775558845165,0.6860556169218849,0.8327137546468402,1.0,1.0,3/10,12.57%,CYBB;NCF4;NOX3
prerank,RNA cap binding (GO:0000339),0.30655671529782336,0.684781930590284,0.8315602836879432,1.0,1.0,7/16,22.19%,EIF3D;CYFIP1;NCBP2;EIF4E;EIF4A1;NCBP1;DCPS
prerank,P-type ion transporter activity (GO:0015662),0.3189033995731979,0.6830820884470761,0.8378378378378378,1.0,1.0,2/12,6.35%,ATP2C1;ATP2B1
prerank,damaged DNA binding (GO:0003684),-0.21511819501486257,-0.6793081192289814,0.9667673716012085,0.9908651539961205,1.0,22/44,36.19%,RBBP8;TDG;DDB2;SMC6;CRY2;XRCC1;EP300;SDE2;ERCC1;CUL4B;NBN;HMGB1;CREBBP;ERCC2;NEIL3;APEX1;FEN1;RAD18;AUNIP;UNG;DCLRE1A;ERCC5
prerank,glutathione transferase activity (GO:0004364),0.28265736913472017,0.6740301290438613,0.8807947019867549,1.0,1.0,4/23,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,thyroid hormone receptor binding (GO:0046966),-0.23522525384348134,-0.670403767723839,0.9295039164490861,0.9951155456531801,1.0,11/28,27.31%,HMGN3;BRD8;TRIP12;MED30;NCOR1;NSD1;MED4;GTF2H1;MED24;MED16;PRMT2
prerank,sodium channel regulator activity (GO:0017080),-0.2221401900705055,-0.6664854186508726,0.9266304347826086,0.9942565172821595,1.0,3/37,3.84%,PTPN3;SNTA1;CAMK2D
prerank,C-C chemokine binding (GO:0019957),0.2757789344498289,0.6643531466315576,0.8793969849246231,1.0,1.0,2/22,8.20%,CCR7;CXCR2
prerank,carboxypeptidase activity (GO:0004180),0.2539823095692088,0.6576337721644515,0.9152,1.0,1.0,5/35,10.49%,MINDY1;VASH1;CPD;AGBL5;MINDY2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2774836768948362,-0.6558979766072358,0.8662131519274376,0.9992508160956047,1.0,4/14,17.41%,SDHB;ACO1;RSAD1;NDUFS1
prerank,kinesin binding (GO:0019894),0.26314856964264377,0.6556266744316656,0.8872549019607843,1.0,1.0,6/27,17.73%,ACTB;CLSTN1;SPAG9;AP1G1;AP1AR;ARHGEF10
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.31958798227716445,0.6538099516119333,0.863063063063063,1.0,1.0,6/11,22.19%,NUDT3;DCP2;NUDT1;NUDT10;NUDT16;DCPS
prerank,magnesium ion binding (GO:0000287),0.20035250532803242,0.652621945881341,0.9854497354497355,1.0,1.0,36/135,22.51%,PDE2A;STK38;SNRK;HPRT1;NT5C3A;MTPAP;PRKACB;IDH3A;MAP3K6;PDXK;HPGDS;NUDT3;DXO;CERK;STK3;FAN1;HACL1;XYLT2;MOV10L1;PDCD6;STK26;MSH2;NLRC4;SIK2;CIB2;TPPP;ADPRS;PGP;NUDT16;MAP2K7;BRSK2;MAST1;SNCA;SIK3;PAPOLA;CDC42BPA
prerank,hormone activity (GO:0005179),-0.20065454006952071,-0.6494761454518455,0.9667673716012085,1.0,1.0,1/54,0.34%,IGF1
prerank,mannose binding (GO:0005537),-0.27133607411482114,-0.6434681616710397,0.8946188340807175,1.0,1.0,9/12,52.27%,LMAN1;LMAN2L;COLEC11;LMAN2;CLEC4D;ACR;CLEC6A;CD207;LMAN1L
prerank,deoxyribonuclease activity (GO:0004536),0.2862487064183068,0.6434290352920375,0.8688524590163934,1.0,1.0,2/14,9.03%,MRE11;DFFB
prerank,beta-tubulin binding (GO:0048487),0.2521548943118626,0.6401973703537271,0.9226973684210527,1.0,1.0,4/31,10.99%,TTLL7;FGF13;CCT5;PEX14
prerank,four-way junction DNA binding (GO:0000400),0.2750833279389945,0.6388423460426492,0.9085923217550275,1.0,1.0,3/17,15.56%,MEN1;HMGB2;MSH2
prerank,snoRNA binding (GO:0030515),-0.22001104811099698,-0.6378431915268634,0.9427792915531336,1.0,1.0,5/30,16.68%,NUDT4;NOP14;XRCC5;GAR1;NOP56
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.28580597994368956,-0.6366075540849496,0.890295358649789,0.9975596984387121,1.0,2/10,15.25%,GABRA3;GABRE
prerank,protein kinase activator activity (GO:0030295),0.2233950195656158,0.6363290624640672,0.9759887005649718,1.0,1.0,6/60,8.39%,AFAP1L2;RGCC;FGF13;CALM1;IRGM;IQGAP1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.30484123460674534,0.6359094611855151,0.8888888888888888,1.0,1.0,3/12,20.49%,SLC25A5;SLC35B3;SLC25A23
prerank,E-box binding (GO:0070888),0.24498804445751723,0.6357131031127462,0.9265175718849841,1.0,1.0,5/34,12.84%,TAL1;SNAI2;MAX;CIART;PPARG
prerank,calcium-activated potassium channel activity (GO:0015269),0.3084526715922521,0.6354112153229634,0.8529411764705882,1.0,1.0,2/11,8.25%,KCNN2;KCNN3
prerank,NADP binding (GO:0050661),0.2510399949273329,0.6333771722930517,0.9315286624203821,1.0,1.0,6/32,14.82%,NOS3;NOS2;CAT;HMGCR;LBR;QDPR
prerank,GDP binding (GO:0019003),-0.1879425521710781,-0.6295479986316747,0.9851190476190477,0.9984033834795675,1.0,18/63,24.91%,ARL3;TRIM23;RAB21;MRAS;RASL12;MIEF1;RHEB;RIT1;RAB29;GNAI3;RAB11B;RAB22A;RAB14;RERG;RAP2A;RAB9A;RAP2C;RASEF
prerank,tRNA binding (GO:0000049),-0.19823597504018983,-0.628468895703973,0.9722991689750693,0.9951084160639898,1.0,20/43,30.77%,TRMT9B;DALRD3;MRPS27;TRMT10B;NSUN2;ALKBH1;ELP5;IGHMBP2;EIF2A;RPUSD4;DARS2;TYW5;FARS2;TRNAU1AP;AIMP1;SEPSECS;PTCD1;KARS1;TERT;CTU1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.24447631676778034,0.6273061914099419,0.9418416801292407,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.24447631676778034,0.6273061914099419,0.9418416801292407,1.0,1.0,7/34,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.29980387427284494,0.6196927158548339,0.8768939393939394,1.0,1.0,2/10,13.58%,ANKRD13A;FAN1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.23056055934918068,-0.6179567731514188,0.9650872817955112,0.9979323180421328,1.0,8/22,22.15%,IKBKE;ZRANB3;ZBTB1;IKBKG;OPTN;ATRIP;WDR81;TAB3
prerank,rRNA binding (GO:0019843),-0.19936129809852748,-0.6124021252601767,0.9887005649717514,0.9972532397407812,1.0,13/42,27.08%,MRPS27;MTERF4;PPAN;EMG1;RCC1L;UTP23;CIRBP;MRPS6;MRPL18;FASTKD2;ERI1;RPS5;NOP53
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.269013293813814,-0.6117293067956922,0.9288702928870293,0.9937170294122072,1.0,3/11,14.99%,PRMT5;PRMT8;PRMT9
prerank,ferrous iron binding (GO:0008198),-0.22738922045687998,-0.6108713296542485,0.961439588688946,0.9903522821137581,1.0,4/21,12.53%,EGLN3;FXN;PHYH;ALKBH1
prerank,neuropeptide binding (GO:0042923),0.2678692936152,0.6074026926853993,0.9180887372013652,1.0,1.0,4/18,25.80%,OPRD1;SSTR1;OPRM1;GPR149
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.26775298874027187,-0.6072235156594759,0.9109730848861284,0.9885306140904117,1.0,3/11,26.27%,SLC25A24;SLC35B2;SLC25A42
prerank,ribonuclease P RNA binding (GO:0033204),0.29232701984916004,0.6054836627362603,0.8869395711500975,1.0,1.0,3/10,21.46%,RPP38;RPP21;RPP30
prerank,omega peptidase activity (GO:0008242),0.19638785469263254,0.6043895598880706,0.9849726775956285,1.0,1.0,22/89,20.20%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;ASRGL1;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1;APEH
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.214730430335706,0.6037071497814371,0.9742813918305597,1.0,1.0,18/57,27.64%,NDUFA2;NDUFA8;NDUFA4;CYB561A3;UQCRC1;NDUFA12;NDUFB3;NDUFC1;UQCRQ;COX10;UQCR11;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19829931742963539,0.6033075263622835,0.9875690607734806,1.0,1.0,20/83,20.14%,USP53;ATXN3;OTUD7A;MYSM1;PAN2;USP18;CYLD;TNFAIP3;COPS5;USP49;JOSD2;USP32;USP29;BRCC3;OTUD4;USP25;USP21;OTUD7B;DESI2;JOSD1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.257991082094404,0.6022109617402636,0.9333333333333333,1.0,1.0,3/21,12.88%,CHRNB1;P2RX7;GRIK2
prerank,exonuclease activity (GO:0004527),0.21949965595504,0.601146261879832,0.9649390243902439,1.0,1.0,16/46,22.45%,MRE11;ENPP2;PDE12;CNOT6;DXO;FAN1;TRIR;ISG20L2;EXOG;REV3L;EXOSC10;EXOSC9;XRN2;RAD1;DCLRE1C;EXOSC8
prerank,phospholipase A2 activity (GO:0004623),0.2456125624122985,0.5999591457605026,0.9541734860883797,1.0,1.0,3/26,14.91%,PLA2G4B;PNPLA8;PRDX6
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.22762646295979988,-0.5997236277352309,0.9600997506234414,0.9889509147603041,1.0,10/20,31.45%,SENP3;OTULINL;USP9X;USP50;OTUB1;SENP5;OTUD5;USP47;YOD1;UFSP2
prerank,U6 snRNA binding (GO:0017070),0.2732493061180169,0.597143610207436,0.922945205479452,1.0,1.0,5/14,25.82%,EIF5A;PRPF4;LSM4;PRPF8;SART3
prerank,pyrophosphatase activity (GO:0016462),0.21671809592929087,0.5942910660021762,0.9770290964777948,1.0,1.0,12/50,22.31%,ENTPD1;ENTPD5;NUDT3;DCP2;DXO;NUDT9;DOLPP1;NUDT1;NUDT10;NUDT16;DCPS;BNIP2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.21722916381005392,-0.5924433521338501,0.9609756097560975,0.9891337555492956,1.0,10/24,28.92%,IGF2BP2;FMR1;DDX3X;LARP6;UTP23;NCL;SHMT1;SYNCRIP;IGF2BP1;DHX36
prerank,RNA polymerase binding (GO:0070063),-0.23475331288140056,-0.5893265425507362,0.945823927765237,0.9869516132255192,1.0,5/18,22.12%,CCNT2;PABPN1;BRCA1;TCERG1;NEDD4
prerank,single-stranded RNA binding (GO:0003727),0.21621482864465644,0.5886618955315324,0.963258785942492,1.0,1.0,15/43,27.14%,IFIH1;EIF4H;TLR7;SNRPC;TLR8;AQR;DDX11;EXOSC10;JMJD6;EIF4B;ADARB2;LONP1;DDX60;HNRNPF;AGO1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.24295607291919352,-0.5864005934763704,0.9407744874715261,0.9845767154620962,1.0,5/14,22.48%,NOX4;CYBA;MICAL1;KMO;NOX1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.2585205866150554,0.5797915642121092,0.9306049822064056,1.0,1.0,2/15,7.17%,SNX3;PLEKHA5
prerank,endodeoxyribonuclease activity (GO:0004520),-0.21925771195537502,-0.5739400364792598,0.9656019656019657,0.9863074917863928,1.0,5/20,15.96%,RBBP8;ENDOV;ZRANB3;ERCC1;RAD50
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.26542014487624455,0.5722632301703146,0.9315068493150684,1.0,1.0,4/13,24.17%,DNA2;FAN1;DICER1;GEN1
prerank,snRNA binding (GO:0017069),0.20749134192124974,0.5679537696349664,0.9860896445131375,1.0,1.0,13/42,25.82%,EFTUD2;SNU13;SNRPC;EIF5A;NCBP2;PRPF4;SNRPB2;LSM4;CCNT1;SF3B3;PRPF8;SNRPA;SART3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2350267708153896,0.5670469497797375,0.9516666666666667,1.0,1.0,4/22,19.35%,MESD;AP2M1;DNAJA1;LRPAP1
prerank,endonuclease activity (GO:0004519),0.20597285703048676,0.5645381612954257,0.9877300613496932,1.0,1.0,16/49,27.15%,NTHL1;PIWIL1;MRE11;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;ERCC4;KHNYN;ZC3H12A;PNKP;AGO1;ENDOU
prerank,microtubule plus-end binding (GO:0051010),0.23845767843967053,0.5642330166989215,0.9323843416370107,1.0,1.0,7/20,21.14%,CLIP1;MAPRE2;MAPRE3;APC;CLIP2;DCTN1;CLASP1
prerank,neuropeptide receptor activity (GO:0008188),0.22164665803681297,0.5620426114521699,0.9657980456026058,1.0,1.0,7/29,25.66%,SORCS1;HCRTR2;NPY5R;SSTR1;GRPR;OPRM1;SORCS3
prerank,endoribonuclease activity (GO:0004521),0.21589671450787548,0.5597813091604004,0.9752475247524752,1.0,1.0,13/32,27.15%,PIWIL1;INTS11;RNASEK;TSNAX;SND1;EXOG;ENDOG;DICER1;RIDA;KHNYN;ZC3H12A;AGO1;ENDOU
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2520419203637118,0.5520080697576816,0.9260628465804066,1.0,1.0,5/14,19.21%,MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.22689358463913467,-0.5484281119599864,0.971677559912854,0.9923351183128936,1.0,2/15,9.43%,P2RX4;P2RY14
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.26808427841713967,0.5447841739481072,0.9531835205992509,1.0,1.0,2/11,16.58%,NTHL1;HMGA2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.22000524730342824,0.5440260218869404,0.9711864406779661,1.0,1.0,8/28,21.46%,EDC3;ELAC1;RPP38;MRPL44;RPP21;DICER1;NUDT16;RPP30
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.20595343555055945,0.5372980346374084,0.9775641025641025,1.0,1.0,9/35,21.25%,NT5C3A;PTRH2;ELAC1;DTWD2;GATC;TRMT12;MRPL58;TRMT5;QTRT2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23730837426121282,0.5335680350181925,0.9739130434782609,1.0,1.0,3/18,21.07%,HSD17B7;HSD17B8;HSD17B10
prerank,acetylcholine receptor activity (GO:0015464),0.22190782756321692,0.5325719390148808,0.9726027397260274,1.0,1.0,2/22,10.93%,CHRNB1;CHRM3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2595870206489677,0.5299626404794153,0.9536541889483066,1.0,1.0,10/10,74.06%,POLD1;DCLRE1C;EXD2;DCLRE1B;MGME1;DCLRE1A;FEN1;APEX1;TATDN1;EXO1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.199521333622704,0.5204470803706719,0.9934533551554828,1.0,1.0,14/37,28.48%,SARS2;SARS1;YARS2;GARS1;TARS3;FARSB;PARS2;CARS1;NARS1;IARS2;HARS1;VARS1;MARS2;LARS2
prerank,telomeric DNA binding (GO:0042162),0.201766210101212,0.5151822721679669,0.9790996784565916,1.0,1.0,4/32,12.47%,HMBOX1;TERF2;ACD;TERF1
prerank,myosin V binding (GO:0031489),0.22637403370024317,0.5062256150820638,0.9628942486085343,1.0,1.0,2/15,10.48%,RAB11A;RAB3B
prerank,nuclear import signal receptor activity (GO:0061608),-0.20787112854626488,-0.5038404942733742,0.9775784753363229,1.0,1.0,5/15,26.85%,KPNA3;KPNB1;HIKESHI;KPNA6;KPNA1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2138550433362642,0.4992191580296457,0.9831649831649831,1.0,1.0,21/21,78.64%,CHRNB1;GRM5;GRIA1;GRM1;CHRNA2;CHRNA6;DRD4;DRD1;CHRNA1;DRD5;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5;CHRNA7;CHRFAM7A;CHRNB2;CHRNA4;ANXA9
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.2197858125791013,0.49505632296693236,0.9726027397260274,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.2197858125791013,0.49505632296693236,0.9726027397260274,1.0,1.0,1/16,3.63%,ATP6V0A1
prerank,androgen receptor binding (GO:0050681),0.2004992895044874,0.49425217382755504,0.9897260273972602,1.0,1.0,13/25,29.83%,PKN1;PRKCB;ZBTB7A;TRIM68;FOXP1;KDM3A;DAXX;CALR;SMARCA4;SNW1;KDM4C;PARK7;PRPF6
prerank,NADPH binding (GO:0070402),0.22544494333423343,0.48623025309018486,0.9746835443037974,1.0,1.0,3/13,14.82%,HMGCR;LBR;QDPR
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2109660832157573,0.47095703120972937,0.974559686888454,1.0,1.0,4/15,24.42%,PRDM9;KMT2C;RBBP5;WDR82
prerank,O-methyltransferase activity (GO:0008171),0.2279597296236111,0.47032972581452004,0.9830827067669173,1.0,1.0,3/10,21.16%,CMTR2;CMTR1;COQ3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.19452525663373038,0.467722155602738,0.9879310344827587,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,G protein-coupled amine receptor activity (GO:0008227),0.19452525663373038,0.467722155602738,0.9879310344827587,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,serotonin receptor activity (GO:0099589),0.19452525663373038,0.467722155602738,0.9879310344827587,1.0,1.0,3/22,14.39%,HTR2A;CHRM3;HTR4
prerank,tRNA methyltransferase activity (GO:0008175),0.2081152929444676,0.4637232299787922,0.9830220713073005,0.9990059154482402,1.0,7/16,26.66%,TRMT12;METTL2A;METTL2B;ALKBH8;TRMT5;TARBP1;TYW3
prerank,methyltransferase activity (GO:0008168),0.1656282258695923,0.45484436509192233,1.0,0.9980404779720384,1.0,15/46,28.31%,LCMT1;EEF1AKMT3;NDUFAF7;MGMT;MRM2;COMTD1;PRMT7;COQ3;METTL3;GCSH;TRMT11;EEF1AKMT4;SUV39H1;DNMT1;DNMT3B
prerank,RNA methyltransferase activity (GO:0008173),-0.17174864521868932,-0.4472338422316503,1.0,1.0,1.0,2/19,9.03%,TRMT9B;TGS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.17351999497771362,-0.4324005569630606,1.0,1.0,1.0,14/14,82.67%,CAPN1;CAPN15;CAPN11;CAPN5;CAPN8;CAPN3;CAPNS2;CAPN9;CAPN13;CAPN6;CAPNS1;CAPN10;CAPN12;CAPN2
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.17666784731294546,-0.4285614548752623,0.9956331877729258,1.0,1.0,3/14,19.15%,PRORP;POP4;TSEN2
prerank,cytochrome-c oxidase activity (GO:0004129),0.18391351574106607,0.4084309999157505,0.9929701230228472,1.0,1.0,7/15,31.46%,NDUFA4;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,ribonuclease P activity (GO:0004526),0.18712425773000063,0.3937359426358339,0.9961538461538462,0.9999785893140147,1.0,3/11,21.46%,RPP38;RPP21;RPP30
prerank,proton transmembrane transporter activity (GO:0015078),-0.1255141833069078,-0.37165683098920677,1.0,0.9995177057634161,1.0,9/39,24.58%,SLC9A1;COX6A1;UQCRFS1;SLC33A1;NNT;ATP6V1F;COX6B1;CLCN4;SLC11A2
prerank,single-stranded DNA helicase activity (GO:0017116),0.14029138407435324,0.3251933999520532,0.9982993197278912,0.9998267905233061,1.0,19/19,85.99%,DNA2;CHTF18;RFC2;RFC4;WRNIP1;MCM6;HELQ;DHX9;RAD51;MCM7;MCM2;CHTF8;POLQ;PIF1;DSCC1;RFC5;MCM5;RFC3;HELB
